UNITED STATES

SECURITIES EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.


	For the quarterly period ended June 30, ~~2020~~2021

☐	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

	For the transition period from ~~____________~~___________ to ~~____________~~___________

STRIKEFORCE TECHNOLOGIES, INC.

(Exact name of registrant as specified in its Charter)

~~WYOMING~~Wyoming

000-55012

22-3827597

~~(State~~(State or other jurisdiction of

incorporation or organization)

(Commission

file number)

~~(I.R.S.~~(I.R.S. Employer

Identification No.)

1090 King Georges Post Road, Suite 603

Edison, NJ 08837

(Address of Principal Executive Offices)

(732) 661-9641

(Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class		Name of each exchange on which registered
N/A		N/A

Securities registered pursuant to Section 12(b) of the Act:

Title of

each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, $0.0001 par value

SFOR

~~OTC~~OTCQB

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☐☒ No ☒

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☒☐ No ☐

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such a shorter period that the registrant was required to submit and post such files). ☒ Yes ☒☐ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,”’ “accelerated filer,”’ “smaller reporting company,”’ and “emerging growth ~~company”~~company’ in Rule ~~12b–2~~12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act.) Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class		Outstanding at August ~~16, 2020~~17, 2021
Common stock, $0.0001 par value		~~15,887,721~~893,504,326

Indicate the number of shares outstanding of each of the issuer’s classes of preferred stock, as of the latest practicable date.

Class		Outstanding at August ~~16, 2020~~17, 2021
Preferred stock, Series A, no par value		3

Class		Outstanding at August ~~16, 2020~~17, 2021
Preferred stock, Series B, $0.10 par value		36,667

Transitional Small Business Disclosure Format Yes ☐ No ☒

Documents Incorporated By Reference

None

STRIKEFORCE TECHNOLOGIES, INC.

INDEX TO FORM 10-Q FILING

JUNE 30, ~~2020~~2021

TABLE OF CONTENTS

		~~Page~~ ~~Number~~

PART I	Financial Information	Page Number

Item 1.	Financial Information	3

	Condensed Consolidated Balance Sheets at June 30, ~~2020~~2021 (unaudited) and December 31, ~~2019~~2020	3

	Condensed Consolidated Statements of Operations for the Three and Six months ended June 30, ~~2020~~2021 and ~~2019~~2020 (unaudited)	4

	Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the Three and Six months ended June 30, ~~2020~~2021 and ~~2019~~2020 (unaudited)	5-6

	Condensed Consolidated Statements of Cash Flows for the Six months ended June 30, ~~2020~~2021 and ~~2019~~2020 (unaudited)	7

	Notes to the Condensed Consolidated Financial Statements for the ~~Three and~~ Six months ended June 30, ~~2020~~2021 and ~~2019~~2020 (unaudited)	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	20

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25

Item 4.	Controls and Procedures	25

PART II	Other Information

Item 1.	Legal Proceedings	2627

Item 1A.	Risk Factors	2627

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	2728

Item 3.	Defaults Upon Senior Securities	2829

Item 4.	Mine Safety Disclosures	2829

Item 5.	Other Information	2829

Item 6.	Exhibits	2930

SIGNATURES		3032

EX-31.1	Management Certification

EX-32.1	Sarbanes-Oxley Act

Table of Contents

PART I

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AND NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

STRIKEFORCE TECHNOLOGIES, INC.	STRIKEFORCE TECHNOLOGIES, INC.							STRIKEFORCE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS	CONDENSED CONSOLIDATED BALANCE SHEETS							CONDENSED CONSOLIDATED BALANCE SHEETS

		June 30, 2020			December 31, 2019				June 30, 2021			December 31, 2020
		(Unaudited)							(Unaudited)
ASSETS
Current Assets:
Cash		$	122,068		$	74,648
Cash (includes VIE balances of $66 and $2,000, respectively)									$	1,348,000		$	162,000
Accounts receivable, net			20,151			19,686				11,000			20,000
Prepaid expenses			5,558			4,557				27,000			21,000

Total current assets			147,777			98,891				1,386,000			203,000

Property and equipment, net			2,791			5,448				1,000			2,000
Operating lease right-of-use asset			181,755			205,970				132,000			157,000
Other assets			15,348			16,376				13,000			14,000

Total Assets		$	347,671		$	326,685			$	1,532,000		$	376,000

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities:
Accounts payable and accrued expenses		$	1,254,955		$	1,115,995
Convertible notes payable (net of discount of $341,321 and $422,705, respectively; including $1,481,100 and $1,438,100 in default, respectively)			1,739,419			1,860,395
Accounts payable and accrued expenses (includes VIE balances of $2,000 and $3,000, respectively)									$	1,034,000		$	1,010,000
Convertible notes payable (net of discount of $0 and $14,000, respectively; including $1,438,000 and $1,435,000 in default, respectively)										1,438,000			1,469,000
Convertible notes payable - related parties			298,000			355,500				268,000			298,000
Notes payable (including $2,142,538 and $2,113,824 in default, respectively)			2,365,684			2,237,484
Notes payable (net of discount of $0 and $52,000, respectively; including $1,969,000 and $2,146,000 in default, respectively) (includes VIE balances of $330,000 and $475,000, respectively)										2,004,000			2,250,000
Notes payable - related parties			752,513			742,513				693,000			952,000
Accrued interest (including $1,378,260 and $1,396,296 due to related parties, respectively)			4,962,132			4,842,215
Accrued interest (including $1,437,000 and $1,448,000 due to related parties, respectively) (includes VIE balances of $113,000 and $109,000, respectively)										5,295,000			5,187,000
Contingent payment obligation			1,500,000			1,500,000				1,500,000			1,500,000
Debt settlement obligation			288,000			-
Financing obligation			1,263,200			1,263,200
Financing obligation (includes VIE balance of $1,263,000 and $1,263,000, respectively)										1,263,000			1,263,000
Operating lease liability, current portion			48,724			46,952				39,000			38,000
Derivative liabilities			984,000			1,516,435				0			163,000

Total current liabilities			15,453,627			15,480,689				13,534,000			14,130,000

Notes payable, long term portion			398,212			147,890				327,000			463,000
Operating lease liability, long term portion			137,275			162,289				99,000			125,000

Total Liabilities			15,992,114			15,790,868				13,960,000			14,718,000

Commitments and Contingencies

Stockholders' Deficit
Series A Preferred stock, no par value; 100 shares authorized; 3 shares issued and outstanding			987,000			987,000				987,000			987,000
Series B Preferred stock par value $0.10: 100,000,000 shares authorized; 36,667 shares issued and outstanding			3,667			3,667				4,000			4,000
Preferred stock series not designated par value $0.10: 10,000,000 shares authorized; none issued or outstanding			-			-				0			0
Common stock par value $0.0001: 14,000,000,000 shares authorized; 9,363,610 and 5,905,388 shares issued and outstanding, respectively			936			591
Common stock par value $0.0001: 4,000,000,000 shares authorized; 876,169,478 and 718,263,338 shares issued and outstanding, respectively										88,000			72,000
Additional paid-in capital			30,563,874			28,674,569				56,701,000			39,814,000
Accumulated deficit			(46,401,808	)		(44,352,595	)			(69,368,000	)		(54,396,000	)
Total StrikeForce Technologies, Inc. stockholders' deficit			(14,846,331	)		(14,686,768	)			(11,588,000	)		(13,519,000	)
Noncontrolling interest in consolidated subsidiary			(798,112	)		(777,415	)			(840,000	)		(823,000	)

Total Stockholders' Deficit			(15,644,443	)		(15,464,183	)			(12,428,000	)		(14,342,000	)

Total Liabilities and Stockholders' Deficit		$	347,671		$	326,685			$	1,532,000		$	376,000

See accompanying notes to the condensed consolidated financial ~~statements~~statements.

Table of Contents

STRIKEFORCE TECHNOLOGIES, INC.	STRIKEFORCE TECHNOLOGIES, INC.													STRIKEFORCE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS	CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS													CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

		For the Three Months Ended						For the Six Months Ended							For the Three Months Ended						For the Six Months Ended
		June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019				June 30, 2021			June 30, 2020			June 30, 2021			June 30, 2020
		(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)				(Unaudited)			(Unaudited)			(Unaudited)			(Unaudited)

Revenue		$	50,884		$	307,739		$	110,844		$	439,426			$	67,000		$	51,000		$	113,000		$	111,000

Operating expenses:
Cost of revenue			6,511			2,210			9,015			6,081				8,000			7,000			11,000			9,000
Compensation			166,569			197,393			331,218			370,912
Professional fees			193,596			115,487			336,110			286,040
Selling, general and administrative expenses			178,956			65,661			379,655			169,031				1,820,000			538,000			7,448,000			1,047,000
Research and development			123,750			123,750			247,500			250,212				129,000			124,000			274,000			248,000

Total operating expenses			669,382			504,501			1,303,498			1,082,276				1,957,000			669,000			7,733,000			1,304,000

Loss from operations			(618,498	)		(196,762	)		(1,192,654	)		(642,850	)			(1,890,000	)		(618,000	)		(7,620,000	)		(1,193,000	)

Other income (expense):
Interest expense (including $65,237 and $63,1560 to related parties, respectively)			(161,679	)		(121,213	)		(333,498	)		(246,242	)
Interest expense (including $61,000 and $65,000 to related parties, respectively)																(114,000	)		(162,000	)		(242,000	)		(333,000	)
Debt discount amortization			(188,112	)		(295,699	)		(407,962	)		(595,165	)			(29,000	)		(188,000	)		(52,000	)		(408,000	)
Financing costs																(3,330,000	)		0			(6,569,000	)		0
Private placement costs			-			(145,511	)		(103,500	)		(342,558	)			0			0			0			(104,000	)
Change in fair value of derivative liabilities			13,000			(521,334	)		212,435			(681,710	)			0			13,000			(219,000	)		212,000
Gain/(loss) on extinguishment of debt			(252,524	)		64,268			(287,376	)		(22,301	)
Other income			42,645			33,266			42,645			33,266
Gain (loss) on extinguishment of debt, net																321,000			(253,000	)		(286,000	)		(287,000	)
Other income (expense)																(1,000	)		43,000			(1,000	)		43,000

Other income (expense), net			(546,670	)		(986,223	)		(877,256	)		(1,854,710	)			(3,153,000	)		(547,000	)		(7,369,000	)		(877,000	)

Net loss			(1,165,168	)		(1,182,985	)		(2,069,910	)		(2,497,560	)			(5,043,000	)		(1,165,000	)		(14,989,000	)		(2,070,000	)

Net loss attributable to noncontrolling interest			12,093			66,589			20,697			178,378				10,000			12,000			17,000			21,000

Net loss attributable to StrikeForce Technologies, Inc.		$	(1,153,075	)	$	(1,116,396	)	$	(2,049,213	)	$	(2,319,182	)		$	(5,033,000	)	$	(1,153,000	)	$	(14,972,000	)	$	(2,049,000	)

Net loss per common share
-Basic and diluted		$	(0.15	)	$	(0.22	)	$	(0.29	)	$	(0.47	)		$	(0.01	)	$	(0.15	)	$	(0.02	)	$	(0.29	)

Weighted average common shares outstanding
-Basic and diluted			7,811,894			4,986,303			7,058,500			4,893,377				847,638,243			7,811,894			812,551,868			7,058,500

See accompanying notes to the condensed consolidated financial ~~statements~~statements.

Table of Contents

STRIKEFORCE TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

~~Table of Contents~~

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021 AND 2020 (Unaudited)

STRIKEFORCE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2020 AND 2019 (Unaudited)

Three months ended June 30, 2020

Series A Preferred
stock, no par value

Series B Preferred
stock, par value $0.10

Common stock,
par value $0.0001

Additional
Paid-in

Accumulated

Noncontrolling

Total
Stockholders'

Shares

Amount

Shares

Amount

Shares

Amount

Capital

Deficit

Interest

Deficit

Balance at April 1, 2020

3

$ 987,000

36,667

$ 3,667

6,751,909

$ 677

$ 29,758,210

$ (45,248,733 )

$ (786,019 )

$ (15,285,198 )

Fair value of common stock issued for services

-

-

-

-

98,865

9

19,999

-

-

20,008

Fair value of vested options

-

-

-

-

-

-

102,054

-

-

102,054

Warrants issued with convertible notes

-

-

-

-

-

-

-

-

-

-

Common stock issued upon conversion of notes and interest

-

-

-

-

2,068,377

206

585,655

-

-

585,861

Common stock issued upon conversion of debt settlement

-

-

-

-

444,459

44

97,956

-

-

98,000

Net loss

-

-

-

-

-

-

-

(1,153,075 )

(12,093 )

(1,165,168 )

Balance at June 30, 2020 (unaudited)

3

$ 987,000

36,667

$ 3,667

9,363,610

$ 936

$ 30,563,874

$ (46,401,808 )

$ (798,112 )

$ (15,644,443 )

Three months ended June 30, 2021

	Series A Preferred stock, no par value				Series B Preferred stock, par value $0.10				Common stock, par value $0.0001				Additional Paid-in			Accumulated			Noncontrolling			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Interest			Deficit
Balance at April 1, 2021		3	$	987,000		36,667	$	4,000		807,277,505	$	81,000	$	50,862,000		$	(64,335,000	)	$	(830,000	)	$	(13,231,000	)

Common stock issued for cash		-		0		-		0		27,750,000		3,000		1,315,000			0			0			1,318,000

Fair value of common stock issued for services		-		0		-		0		573,184		0		41,000			0			0			41,000

Fair value of vested options		-		0		-		0		-		0		1,157,000			0			0			1,157,000

Fair value of common stock issued as a financing cost		-		0		-		0		28,219,063		3,000		3,327,000									3,330,000

Common stock issued upon cashless exercise of warrants		-		0		-		0		12,349,726		1,000		(1,000	)								0

Net loss		-		0		-		0		-		0		0			(5,033,000	)		(10,000	)		(5,043,000	)

Balance at June 30, 2021 (unaudited)		3	$	987,000		36,667	$	4,000		876,169,478	$	88,000	$	56,701,000		$	(69,368,000	)	$	(840,000	)	$	(12,428,000	)

Six months ended June 30, 2020

Series A Preferred
stock, no par value

Series B Preferred
stock, par value $0.10

Common stock,
par value $0.0001

Additional
Paid-in

Accumulated

Noncontrolling

Total
Stockholders'

Shares

Amount

Shares

Amount

Shares

Amount

Capital

Deficit

Interest

Deficit

Balance at January 1, 2020

3

$ 987,000

36,667

$ 3,667

5,905,388

$ 591

$ 28,674,569

$ (44,352,595 )

$ (777,415 )

$ (15,464,183 )

Fair value of common stock issued for services

-

-

-

-

98,880

10

20,012

-

-

20,022

Fair value of vested options

-

-

-

-

-

-

216,426

-

-

216,426

Warrants issued with convertible notes

-

-

-

-

-

-

37,500

-

-

37,500

Common stock issued upon conversion of notes and interest

-

-

-

-

2,914,883

291

1,517,411

-

-

1,517,702

Common stock issued upon conversion of debt settlement

-

-

-

-

444,459

44

97,956

-

-

98,000

Net loss

-

-

-

-

-

-

-

(2,049,213 )

(20,697 )

(2,069,910 )

Balance at June 30, 2020 (unaudited)

3

$ 987,000

36,667

$ 3,667

9,363,610

$ 936

$ 30,563,874

$ (46,401,808 )

$ (798,112 )

$ (15,644,443 )

Six months ended June 30, 2021

	Series A Preferred stock, no par value				Series B Preferred stock, par value $0.10				Common stock, par value $0.0001				Additional Paid-in			Accumulated			Noncontrolling			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Capital			Deficit			Interest			Deficit
Balance at January 1, 2021		3	$	987,000		36,667	$	4,000		718,263,338	$	72,000	$	39,814,000		$	(54,396,000	)	$	(823,000	)	$	(14,342,000	)

Common stock issued for cash		-		0		-		0		65,866,450		6,000		2,761,000			0			0			2,767,000

Fair value of common stock issued for services		-		0		-		0		701,711		0		57,000			0			0			57,000

Fair value of vested options		-		0		-		0		-		0		6,387,000			0			0			6,387,000

Fair value of common stock issued as a financing cost		-		0		-		0		45,150,500		5,000		6,564,000			0			0			6,569,000

Common stock issued upon cashless exercise of warrants		-		0		-		0		12,349,726		1,000		(1,000	)		0			0			0

Common stock issued upon cashless exercise of options		-		0		-		0		17,208,335		2,000		(2,000	)		0			0			0

Common stock issued upon conversion of notes and accrued interest		-		0		-		0		16,168,589		2,000		1,033,000			0			0			1,035,000

Common stock issued upon conversion of debt settlement		-		0		-		0		460,829		0		88,000			0			0			88,000

Net loss		-		0		-		0		-		0		0			(14,972,000	)		(17,000	)		(14,989,000	)

Balance at June 30, 2021 (unaudited)		3	$	987,000		36,667	$	4,000		876,169,478	$	88,000	$	56,701,000		$	(69,368,000	)	$	(840,000	)	$	(12,428,000	)

See accompanying notes to the condensed consolidated financial ~~statements~~statements.

Table of Contents

STRIKEFORCE TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

~~Table of Contents~~

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021 AND 2020 (Unaudited)

STRIKEFORCE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2020 AND 2019 (Unaudited)

Three months ended June 30, 2019

Series A Preferred
stock, no par value

Series B Preferred
stock, par value $0.10

Common stock,
par value $0.0001

Additional
Paid-in

Accumulated

Noncontrolling

Total
Stockholders'

Shares

Amount

Shares

Amount

Shares

Amount

Capital

Deficit

Interest

Deficit

Balance at April 1, 2019

3

987,000

36,667

3,667

4,894,399

489

27,167,476

(42,027,396 )

(667,259 )

(14,536,293 )

Fair value of common stock issued for services

-

-

-

-

15

1

26

-

-

27

Fair value of vested options

-

-

-

-

-

-

961

-

-

961

Common stock issued upon conversion of notes and interest

-

-

-

-

237,951

24

445,469

-

-

445,493

Net loss

-

-

-

-

-

-

-

(1,116,396 )

(66,589 )

(1,182,985 )

Balance at June 30, 2019 (Unaudited)

3

$ 987,000

36,667

$ 3,667

5,132,365

$ 514

$ 27,613,932

$ (43,143,792 )

$ (734,118 )

$ (15,272,797 )

Three months ended June 30, 2020

	Series A Preferred stock, no par value				Series B Preferred stock, par value $0.10				Common stock, par value $0.0001				Additional Paid-in		Accumulated			Noncontrolling			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Interest			Deficit
Balance at April 1, 2020		3	$	987,000		36,667	$	4,000		6,751,909	$	1,000	$	29,758,000	$	(45,249,000	)	$	(786,000	)	$	(15,285,000	)

Fair value of common stock issued for services		-		0		-		0		98,865		0		20,000		0			0			20,000

Fair value of vested options		-		0		-		0		-		0		102,000		0			0			102,000

Common stock issued upon conversion of notes payable and accrued interest		-		0		-		0		2,068,377		0		586,000		0			0			586,000

Common stock issued upon conversion of debt settlement		-		0		-		0		444,459		0		98,000		0			0			98,000

Net loss		-		0		-		0		-		0		0		(1,153,000	)		(12,000	)		(1,165,000	)

Balance at June 30, 2020 (Unaudited)		3	$	987,000		36,667	$	4,000		9,363,610	$	1,000	$	30,564,000	$	(46,402,000	)	$	(798,000	)	$	(15,644,000	)

Six months ended June 30, 2019
Six months ended June 30, 2020																								Six months ended June 30, 2020

																									Series A Preferred stock, no par value				Series B Preferred stock, par value $0.10				Common stock, par value $0.0001				Additional Paid-in		Accumulated			Noncontrolling			Total Stockholders'
	Series A Preferred stock, no par value				Series B Preferred stock, par value $0.10				Common stock, par value $0.0001				Additional Paid-in		Accumulated			Noncontrolling			Total Stockholders'				Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Interest			Deficit
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Interest			Deficit
Balance at January 1, 2019		3		987,000		36,667		3,667		4,747,499		475		26,586,704		(40,824,610	)		(555,740	)		(13,802,504	)
Balance at January 1, 2020																										3	$	987,000		36,667	$	4,000		5,905,388	$	1,000	$	28,675,000	$	(44,353,000	)	$	(777,000	)	$	(15,463,000	)

Fair value of common stock issued for services		-		-		-		-		30		1		95		-			-			96				-		0		-		0		98,880		0		20,000		0			0			20,000

Fair value of vested options		-		-		-		-		-		-		1,912		-			-			1,912				-		0		-		-		-		-		216,000		0			0			216,000

Fair value of warrants issued with convertible notes		-		-		-		-		-		-		-		-			-			-				-		0		-		0		-		0		38,000		0			0			38,000

Common stock issued upon conversion of notes and interest		-		-		-		-		384,836		38		1,025,221		-			-			1,025,259				-		0		-		0		2,914,883		0		1,517,000		0			0			1,517,000

Common stock issued upon conversion of debt settlement																										-		0		-		0		444,459		0		98,000		0			0			98,000

Net loss		-		-		-		-		-		-		-		(2,319,182	)		(178,378	)		(2,497,560	)			-		0		-		0		-		0		0		(2,049,000	)		(21,000	)		(2,070,000	)

Balance at June 30, 2019 (Unaudited)		3	$	987,000		36,667	$	3,667		5,132,365	$	514	$	27,613,932	$	(43,143,792	)	$	(734,118	)	$	(15,272,797	)
Balance at June 30, 2020 (Unaudited)																										3	$	987,000		36,667	$	4,000		9,363,610	$	1,000	$	30,564,000	$	(46,402,000	)	$	(798,000	)	$	(15,644,000	)

See accompanying notes to the condensed consolidated financial ~~statements~~statements.

Table of Contents

STRIKEFORCE TECHNOLOGIES, INC.	STRIKEFORCE TECHNOLOGIES, INC.							STRIKEFORCE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS	CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS							CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

									For the Six Months			For the Six Months
									Ended			Ended
		For the Six Months Ended June 30, 2020			For the Six Months Ended June 30, 2019				June 30, 2021			June 30, 2020
		(Unaudited)			(Unaudited)				(Unaudited)			(Unaudited)
Cash flows from operating activities:
Net loss		$	(2,069,910	)	$	(2,497,560	)		$	(14,989,000	)	$	(2,070,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			3,685			3,698				3,000			4,000
Amortization of discount on notes payable			407,962			595,165
Amortization of discount										52,000			408,000
Amortization of right-of-use asset			24,215			14,627				25,000			24,000
Fair value of common stock issued for services			20,022			96				57,000			20,000
Fair value of vested options			216,426			1,912				6,387,000			216,000
Fair value of common stock issued for financing services										6,569,000			26,000
Change in fair value of derivative liabilities			(212,435	)		681,710				219,000			(212,000	)
Private placement costs			103,500			342,558				0			104,000
Fair value of shares issued for interest expense			26,000			-
Loss on extinguishment of debt			287,376			22,301				286,000			287,000
Changes in operating assets and liabilities:
Accounts receivable			(465	)		(52,391	)			8,000			(1,000	)
Prepaid expenses			(1,001	)		3,884				(6,000	)		(1,000	)
Accounts payable and accrued expenses			163,585			(30,522	)			(1,000	)		164,000
Accrued interest			264,180			245,993				144,000			264,000
Operating lease liability			(23,242	)		(13,261	)			(25,000	)		(23,000	)
Net cash used in operating activities			(790,102	)		(681,790	)			(1,271,000	)		(790,000	)

Cash flows from financing activities:
Proceeds from sale of common stock										2,767,000			0
Proceeds from convertible notes payable			471,000			578,000				0			471,000
Proceeds from notes payable			543,161			-				177,000			543,000
Proceeds from notes payable-related parties			10,000			-				0			10,000
Repayment of convertible note payable			(43,000	)		-				0			(43,000	)
Repayment of notes payable			(143,639	)		(5,000	)			(198,000	)		(144,000	)
Proceeds from finance obligation			-			112,500
Repayment of convertible notes payable-related parties										(30,000	)		0
Repayment of notes payable-related parties										(259,000	)		0
Net cash provided by financing activities			837,522			685,500				2,457,000			837,000

Net increase in cash			47,420			3,710
Net decrease in cash										1,186,000			47,000

Cash at beginning of the period			74,648			86,160				162,000			75,000

Cash at end of the period		$	122,068		$	89,870			$	1,348,000		$	122,000

Supplemental disclosure of cash flow information:
Interest paid		$	50,918		$	-			$	111,000		$	51,000
Income tax paid		$	-		$	-			$	0		$	0

Supplemental disclosure of non-cash investing and financing transactions
Fair value of derivative upon issuance of convertible debt recorded as debt discount		$	471,000		$	578,000			$	0		$	471,000
Right-of-use assets obtained in exchange for operating lease obligations		$	-		$	214,272
Common stock issued for conversion of notes and accrued interest		$	1,517,702		$	1,025,259			$	1,035,000		$	1,518,000
Convertible note, accrued interest, and accounts payable assumed by debt settlement obligation		$	197,738		$	-			$	0		$	198,000
Common stock issued for payment of debt settlement obligation		$	98,000		$	-
Convertible note and accrued interest exchanged for common stock, net of discount		$	684,011		$	-
Common shares issued upon conversion of debt settlement									$	88,000		$	98,000
Notes payable and accrued interest exchanged for financing obligation		$	-		$	315,200			$	0		$	684,000
Warrants issued with convertible notes		$	37,500		$	-			$	0		$	38,000

See accompanying notes to the condensed consolidated financial ~~statements~~statements.

Table of Contents

��

StrikeForce Technologies, Inc.

Notes to the Condensed Consolidated Financial Statements

Three and six months ended June 30, ~~2020~~2021 and ~~2019~~2020

(Unaudited)

Note 1 - Organization and Summary of Significant Accounting Policies

StrikeForce Technologies, Inc. (the “Company”) is a software development and services company that offers a suite of integrated computer network security products using proprietary technology. The Company’s operations are based in Edison, New Jersey.

Basis of Presentation-Unaudited Interim Financial Information

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods have been included. The results of operations for the six months ended June 30, ~~2020~~2021 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, ~~2020.~~2021. These financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, ~~2019~~2020 and notes thereto contained in the Annual Report on Form 10-K of the Company as filed with the SEC on ~~May 1, 2020.~~April 13, 2021.

The consolidated financial statements include the accounts of the Company and its ~~controlled~~ subsidiary, BlockSafe Technologies, Inc. (“BST”). BST is owned 49% by the Company and 31% by three executive officers of the Company. BST meets the definition of a variable interest entity (“VIE”) and based on the determination that the Company ~~which combined represents an 80% controlling interest in BST. Accordingly,~~is the primary beneficiary of BST, isBST’s operating results, assets and liabilities are consolidated by the Company. Intercompany balances and transactions have been eliminated in consolidation. At June 30, ~~2020,~~2021, noncontrolling interests represents 51% of BST that the Company does not directly own. The Company and BST have a management agreement pursuant to which BST shall remit a management fee of $36,000 per month to the Company, and when BST reaches a milestone of $1,000,000 in financing, an additional management fee of $5,000,000 shall be owed to the Company, payable monthly over three years. The management fee is currently eliminated in consolidation. At June 30, 2021 and December 31, 2020, the amount of VIE cash on the accompanying consolidated balance cash can be used only to settle obligations of BST, and the amounts of VIE accounts payable, VIE Notes Payable, VIE Accrued Interest, and VIE Financing Obligation have no recourse to the general credit of the Company.

~~Reverse Stock Split~~

Effective June 25, 2020, the Company completed a 1:500 reverse stock split of the Company’s issued and outstanding shares of common stock and all fractional shares will be rounded up. All share and per share amounts in the accompanying financial statements have been adjusted retroactively to reflect the reverse stock split as if it had occurred at the beginning of the earliest period presented.

COVID-19

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, has adversely affected workforces, customers, economies, and financial markets globally. It has also disrupted the normal operations of many businesses. This outbreak could decrease spending, adversely affect demand for the Company’s products, and harm the Company’s business and results of operations. In

During the ~~quarter~~six months ended June 30, 2021 and the year ended December 31, 2020, the Company believes the COVID-19 pandemic did impact its operating ~~results as~~results. For the year ended December 31, 2020, sales to customers indecreased by 73% as compared to the ~~second quarter were down 17% from the first quarter of the~~prior year. However, the Company has not observed any impairments of its assets or a significant change in the fair value of its assets due to the COVID-19 pandemic. At this time, it is not possible for the Company to predict the duration or magnitude of the adverse results of the outbreak and its effects on the Company’s business or results of operations, financial condition, or liquidity.

~~As of June 30, 2020, the~~The Company has been following the recommendations of ~~local~~ health authorities to minimize exposure risk for its team members ~~for~~during the ~~past several weeks,~~pandemic, including the temporary closure of its corporate office and having team members work remotely. ~~Most~~During the second quarter of 2021, the Company reopened its corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments.

Reverse Split

On June 25, 2020, the Company completed a 1:500 reverse stock split of its issued and outstanding shares of common stock and all fractional shares were rounded up. All share and per share amounts have been adjusted retroactively to reflect the reverse stock split as if it had occurred at the beginning of the earliest period presented.

Table of Contents

Going Concern

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the six months ended June 30, ~~2020,~~2021, the Company incurred a net loss of ~~$2,069,910~~$14,989,000 and used cash in operating activities of ~~$790,102~~$1,271,000 and at June 30, ~~2020,~~2021, the Company had a stockholders’ deficit of ~~$15,644,443.~~$12,428,000. Also, at June 30, ~~2020,~~2021, the Company is in default on notes payable and convertible notes payable in the aggregate amount of ~~$3,623,638.~~$3,407,000. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that these financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, ~~2019~~2020 financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

~~Table of Contents~~

At June 30, ~~2020,~~2021, the Company had cash on hand in the amount of ~~$122,068. Subsequent to June 30, 2020, the Company issued three unsecured convertible promissory notes for proceeds of $159,500.~~$1,348,000. Management estimates that the current funds on hand will be sufficient to continue operations through the next ~~six~~nine months. The Company’s ability to continue as a going concern is dependent upon its ability to continue to implement its business ~~plan~~plan. Currently, management is attempting to increase revenues by selling through a channel of distributors, value added resellers, strategic partners and original equipment manufacturers. While the Company believes in the viability of its strategy to increase revenues, there can be no assurances to that effect. The Company’s ability to continue as a going concern is dependent upon its ability to increase its customer base and realize increased revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its operations, in the case of debt financing, or cause substantial dilution for its stockholders, in the case of equity financing.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include those related to accounting for financing obligations, assumptions used in valuing stock instruments issued for services, assumptions used in valuing derivative liabilities, the valuation allowance for deferred tax assets, and the accrual of potential liabilities. Actual results could differ from those estimates.

Revenue Recognition

The Company follows the guidance of Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses of our ProtectID®, GuardedID®, MobileTrust® and ~~MobileTrust®~~SafeVchat™ products. The Company usually recognizes subscription revenue over a one-month period based on a typical monthly renewal cycle in accordance with its customer agreement terms. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered.

The Company offers no discounts, rebates, rights of return, or other allowances to clients which would result in the establishment of reserves against service revenue. Additionally, to date, the Company has not incurred incremental costs in obtaining customer contracts.

Cost of revenue includes direct costs and fees related to the sale of our products.

Table of Contents

The following tables present our revenue disaggregated by major product and service lines:

	Three months ended				Three months ended
	June 30, 2020		June 30, 2019		June 30, 2021		June 30, 2020
Software	$	49,093	$	264,577	$	64,000	$	49,000
Service		1,791		43,162		3,000		2,000
Total revenue	$	50,884	$	307,739	$	67,000	$	51,000

Six months ended

June 30,
2020

June 30,
2019

Software

$ 107,567

$ 390,791

Service

3,277

48,635

Total revenue

$ 110,844

$ 439,426

~~Table of Contents~~

	Six months ended
	June 30, 2021		June 30, 2020
Software	$	109,000	$	108,000
Service		4,000		3,000
Total revenue	$	113,000	$	111,000

Fair Value of Financial Instruments

The Company follows the authoritative guidance issued by the Financial Accounting Standards Board (“FASB”) for fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy was established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

Level ~~1—Quoted~~1-Quoted prices in active markets for identical assets or liabilities.

Level ~~2—Inputs,~~2-Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level ~~3—Unobservable~~3-Unobservable inputs based on the ~~Company’s~~Company's assumptions.

The Company is required to use of observable market data if such data is available without undue cost and effort.

The Company believes the carrying amounts reported in the balance sheet for accounts receivable, accounts payable, accrued expenses, convertible notes, and notes payables approximate fair values because of the short-term nature of these financial instruments.

As of ~~June 30, 2020 and~~ December 31, ~~2019,~~2020, the Company’s balance sheet ~~includes~~included Level 2 liabilities comprised of the fair value of embedded derivative liabilities of ~~$984,000 and $1,516,435, respectively~~$163,000 (see Note 9)8).

Derivative Financial Instruments

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The Company evaluates embedded conversion features within its convertible debt to determine whether the embedded conversion features should be bifurcated from the host instrument and accounted for as a derivative. The fair value of the embedded derivatives are determined using Monte Carlo simulation method at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.

Stock-Based Compensation

The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation –- Stock Compensation (Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

The fair value of the Company’s stock options and warrants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

Table of Contents

Loss per Share

Basic loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding, plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Diluted loss per share excludes all potential common shares if their effect is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would be anti-dilutive:

Six months ended

June 30,
2020

June 30,
2019

Options to purchase common stock

633,000

519,000

Warrants to purchase common stock

150,575

-

Convertible notes

8,031,979

355,709

Convertible Series B Preferred stock

387,984

33,651

Total

9,203,538

908,360

~~Table of Contents~~

	Six months ended
	June 30, 2021		June 30, 2020
Options to purchase common stock		40,633,001		633,000
Warrants to purchase common stock		14,965,221		150,575
Convertible notes		21		8,031,979
Convertible Series B Preferred stock		1,040,756		387,984
Total		56,638,999		9,203,538

Concentrations

For the six months ended June 30, 2021, sales to three customers comprised 39%, 31% and 16% of revenues, respectively. For the six months ended June 30, 2020, sales to two customers comprised ~~71%~~65% and ~~14% of revenues, respectively. For the six months ended June 30, 2019, sales to three customers comprised 64%, 19% and 11%~~12% of revenues, respectively. At June 30, ~~2020,~~2021, two customers comprised ~~49%~~62% and ~~32%~~12% of accounts receivable, respectively.

The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. At June 30, ~~2020,~~2021, the Company ~~did not have~~had cash deposits that exceeded the federally insured limit of $250,000 per account. The Company believes that no significant concentration of credit risk exists with respect to its cash balances because of its assessment of the creditworthiness and financial viability of the financial institution.

~~Reclassification~~Segments

The Company operates in one segment for the development and distribution of our software products. In ~~presenting~~accordance with the “Segment Reporting” Topic of the ASC, the Company’s ~~consolidated statements of operations~~chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the ~~three~~entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and ~~six months ended June 30, 2019,~~to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base, single sales team, marketing department, customer service department, operations department, finance and accounting department to support its operations and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company presented the loss on extinguishment of debt of ($271,356) and ($700,993), respectively, and a gain on extinguishment of related derivatives of $335,624 and $678,692, respectively, as two separate amounts. In presenting the Company’s consolidated statements of operations for the three and six months ended June 30, 2020, the Company has reclassified the two amounts into $64,268 and ($22,301), respectively, of gain/(loss) on extinguishment of debtoperates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying consolidated statements of operations for the three and six months ended June 30, 2019. This reclassification has no effect on the results of operations, stockholders’ deficit, and cash flows previously reported.financial statements.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”). ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows.

In August 2020, the FASB issued ASU No. 2020-06, ~~Debt—Debt~~Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and ~~Hedging—Contracts~~Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 will simplify the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models will result in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 will be effective January 1, 2024, for the Company. Early adoption is permitted, but no earlier than January 1, 2021, including interim periods within that year. Management is currently evaluating the effect of the adoption of ASU 2020-06 on the consolidated financial statements, but currently does not believe ASU 2020-06 will have a significant impact on the Company’s accounting for its convertible debt instruments as they are not considered indexed to the Company’s own stock. The effect will largely depend on the composition and terms of the financial instruments at the time of adoption.

Table of Contents

In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU 2021-04 provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. An issuer measures the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange. ASU 2021-04 introduces a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. Early adoption is permitted for all entities, including adoption in an interim period. If an entity elects to early adopt ASU 2021-04 in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The adoption of ASU 2021-04 is not expected to have a material impact on the Company’s financial statements or disclosures.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the ~~Company’s~~Company's present or future consolidated financial statements.

~~Table of Contents~~

Note 2 - Convertible Notes Payable

Convertible notes payable consisted of the following:

	June 30, 2020			December 31, 2019			June 30, 2021		December 31, 2020
Secured
(a) DART/Citco Global, in default	$	542,588		$	542,588		$	543,000	$	543,000

Unsecured
(b) Convertible notes with fixed conversion prices, in default		895,512			895,512			895,000		895,000
(c) Convertible notes with adjustable conversion prices ($43,000 in default at June 30, 2020)		642,640			845,000
(c) Convertible notes with adjustable conversion prices								0		45,000
Total convertible notes principal outstanding		2,080,740			2,283,100			1,438,000		1,483,000
Debt discount		(341,321	)		(422,705	)		0		(14,000	)
Convertible notes, net of discount	$	1,739,419		$	1,860,395		$	1,438,000	$	1,469,000

___________

	(a)	~~At December 31, 2019 and June 30, 2020, convertible~~During fiscal 2005, the Company issued notes ~~payables due~~payable to DART/Citco Global ~~totaled $542,588.~~in the aggregate of $543,000. The notes ~~are~~bear interest at an average rate of 7.5% per annum, matured in December 2010, convertible to common shares at a fixed conversion price of $3.25 per share, as adjusted for applicable reverse stock splits, and secured by all of the Company’s ~~assets, were due in 2010, and are currently in default. Beginning in~~assets. In fiscal 2009, the note ~~holder~~holders agreed to the forbearance of any interest on the notes payable to DART/Citco Global. ~~The DART/Citco Global note payables are convertible into less than one share of~~In August 2021, the ~~Company’s common stock~~notes were assigned to Aktieselskabet Arbejdernes Landsbank (“AL-Bank”), a financing institution based ~~on a fixed conversion price adjusted for applicable reverse stock splits.~~in Denmark.

	~~(b)~~	At June 30, 2021 and December 31, ~~2019 and June 30,~~ 2020, the outstanding balance of convertible notes payable ~~with fixed conversion prices totaled $895,512.~~amounted to $543,000, respectively and in default.

(b)	During fiscals 2005 through 2007, the Company issued notes payable in the aggregate of $895,000. The notes are unsecured, bear interest at a rate starting at 8% up to 18% per annum, were due on various dates from March 2008 to March 2015, and are currently in default. The aggregate notes are convertible into less than one share of the Company’s common stock based on fixed conversion prices adjusted for applicable reverse stock splits. At December 31, 2019, the balance of the accrued interest on the fixed convertible notes was $1,154,095. During the six months ended June 30, 2020, interest of $37,463 was accrued. At June 30, 2020, the balance of accrued interest on the fixed convertible notes was $1,191,558.

	~~(c)~~	At June 30, 2021 and December 31, ~~2019, there were $845,000~~2020, the outstanding balance of convertible notes ~~with adjustable conversion prices outstanding. During the six months ended June 30, 2020, convertible notes for $471,000 were issued, a convertible note for $43,000 was repaid,~~payable amounted to $895,000, respectively and convertible notes for $630,360 were converted into shares of the Company’s common stock (see discussions below). At June 30, 2020, the balance of the convertible notes with adjustable conversion prices was $642,640.in default.

	(c)	During ~~the six months ended June 30,~~fiscal 2020, the Company issued ~~six~~ convertible notes payable with adjustable conversion prices ~~to four lenders~~ for aggregate proceeds of ~~$471,000, bearing~~$803,000. The notes bear interest at 8% to 10% per annum, unsecured, and maturing between October 2020 and ~~March~~December 2021. At the option of the holder, the notes are convertible into shares of common stock of the Company at a price per share discount of 58% to ~~62%~~70% of the market price of the Company’s common stock, as defined, for 15 to 25 days preceding a conversion notice. ~~As a result, the~~The Company determined that the conversion options of the convertible notes were not considered indexed to the Company’s own stock and characterized the ~~fair value of the~~ conversion features as derivative liabilities upon ~~issuance.~~issuance (see Note 10). The Company determined that upon issuance of the convertible notes during the six months ended June 30, 2020, the initial fair value of the embedded conversion feature totaled $535,000 (see Note 9), of which $431,500 was recorded as debt discount to be amortized over the term of the related notes, and the remainder of $103,500 was recorded as private placement costs. In addition, one of the convertible notes issued during the six months ended June 30, 2020, was issued withalso granted warrants to certain note holders to purchase ~~50,000~~638,000 shares of the Company’s common ~~stock (see Note 11). The~~stock. As a result, the Company ~~determined~~recorded debt discount of $803,000, to account the fair value of the derivative liabilities of $742,000, the relative fair value of the warrants ~~was $37,500, which was recorded as debt discount to be amortized over~~granted of $53,000 and direct fees incurred of $8,000. At December 31, 2020, the ~~term~~outstanding balance of the ~~related note.~~notes payable amounted to $45,000 and unamortized discount was $14,000.

	During the six months ended June 30, ~~2020, lenders elected to convert eleven~~2021, notes payable totaling ~~$630,360~~$45,000 plus unpaid interest and fees of ~~$53,650 (total~~$4,000, for a total of ~~$684,010)~~$49,000, were converted into ~~2,914,883~~16,168,589 shares of the Company’s common stock ~~at conversion prices ranging from $0.06 to $0.95 per share. On the dates of conversion, the closing price of the Company’s common stock ranged from $0.15 to $1.65 per share for~~with a ~~total~~ fair value of ~~shares of $1,517,702.~~$1,035,000. The Company followed the general extinguishment model to record the conversion and settlement of the debt. ~~The liabilities for the debt and conversion feature totaled $1,392,589, and was made up of debt and~~Notes payable, accrued interest ~~of $684,010,~~and fees converted totaled $49,000, the related unamortized debt discount oftotaled ($~~144,422)~~14,000), and the derivative liability related to the conversion option of ~~the debt,~~these notes, after final valuation, ~~of $853,000.~~amounted to $382,000. The ~~shares issued were measured at their~~ fair value of ~~$1,517,702,~~the common shares issued amounted to $1,035,000 and the difference between the total debt settled and fair value of ~~$125,114~~the common shares issued amounted to $618,000 and was recorded as loss on extinguishment of debt.

	At ~~December 31, 2019,~~June 30, 2021, the ~~balance of unamortized discount on~~Company had no more convertible notes with adjustable conversion features was $422,705. During the six months ended June 30, 2020, debt discount of $471,000 was recorded, debt discount amortization of $407,962 was recorded, and $144,422 of debt discount was removed related to debt that was converted. At June 30, 2020, the balance of the unamortized discount was $341,321. prices outstanding.

Table of Contents

Note 3 - Convertible Notes Payable –- Related Parties

~~At December 31, 2019,~~In previous years, the Company issued convertible notes ~~payable -~~to related parties totaled $355,500. During the six months ended June 30, 2020, two notes aggregating $57,500 held by the Company’s VP of Technology were extinguished as part of a debt settlement obligation transaction (see Note 8). At June 30, 2020, the balance of convertible notes payable-related parties totaled $298,000.parties/officers in exchange for cash and/or services rendered. The notes are ~~made up of ten convertible note payables,~~unsecured and are due on December 31, 2021. The notes are unsecured, and have ~~extended~~ due dates of December 31, ~~2020. Six~~2021, as amended. Certain notes ~~totaling $268,000~~payable are due to the Company’s Chief Executive Officer ~~at a compounded interest rate of 8% per annum;~~ and ~~four notes totaling $30,000 are due to the spouse of the Company’s Chief Technology Officer at~~have a compounded interest rate of 8% per annum. The aggregate notes are convertible into less than one share of the Company’s common stock at fixed conversion prices adjusted for applicable reverse stock splits. As of December 31, 2020, the outstanding balance of the notes payable amounted to $298,000.

~~At December 31, 2019, accrued interest due for the convertible notes – related parties was $636,272.~~ During the six months ended June 30, ~~2020, interest of $37,274 was accrued, and accrued interest of $82,212 due to the Company’s VP of Technology was extinguished as part of a debt settlement obligation transaction (see Note 8).~~2021, notes payable aggregating $30,000 were repaid. At June 30, ~~2020, accrued interest due for~~2021, the balance of convertible notes ~~– related~~payable-related parties ~~was $591,334.~~totaled $268,000.

Note 4 - Notes Payable

Notes payable consisted of the following:

	June 30, 2020			December 31, 2019			June 30, 2021			December 31, 2020
Unsecured notes
(a) Notes payable-in default	$	1,638,824		$	1,638,824		$	1,639,000		$	1,699,000
(b) Notes payable issued by BST-in default		475,000			475,500			330,000			475,000
(c) Note payable-PPP loan		313,212			-
(c) Note payable-PPP loans								177,000			313,000
(d) Note payable-EID loan		150,000			-			150,000			150,000

Secured notes payable
(e) Notes payable ($28,714 in default at June 30, 2020)		186,860			271,550
(e) Notes payable								35,000			128,000
Total notes payable principal outstanding		2,763,896			2,385,374			2,331,000			2,765,000
Less current portion of notes payable		(2,365,684	)		(2,237,484	)
Debt discount								0			(52,000	)
Less current portion of notes payable, net of discount								(2,004,000	)		(2,250,000	)
Long term notes payable	$	398,212		$	147,890		$	327,000		$	463,000

	(a)	~~At December 31, 2019 and June 30, 2020,~~In previous years, the Company issued notes payable ~~totaled $1,638,824.~~in exchange for cash. The notes are unsecured, bear interest at a rate of 8% tothrough 14% per annum ~~are unsecured,~~ and ~~were due on various dates from December~~matured starting in fiscal 2011 up to ~~July 2017 and are currently in default. At~~November 2021. As of December 31, ~~2019,~~2020, the outstanding balance of ~~the accrued interest on the~~these notes payable ~~was $2,183,352. During the six months ended June 30, 2020, $83,798~~amounted to $1,699,000 and unamortized debt discount of ~~interest was accrued. At June 30, 2020, accrued interest on the promissory notes payable was $2,267,151.~~$52,000.

	~~(b)~~	At December 31, 2019 and June 30, 2020, the Company’s consolidated subsidiary BST (see Note 1) had $475,500 of outstanding promissory notes. The notes bear interest at 8% per annum, are unsecured, matured through September 2019, and are currently in default. In conjunction with these notes, the Company recorded a related financing obligation (See Note 6). At December 31, 2019, the balance of the accrued interest on the notes payable-BST was $70,545. During the six months ended June 30, ~~2020, $18,948~~2021, $60,000 of ~~interest was accrued.~~the notes were paid and the Company amortized the debt discount of $52,000. At June 30, ~~2020, accrued interest on~~2021, the outstanding balance of the notes ~~payable-BST~~payable was ~~$89,493.~~$1,639,000 and deemed in default.

Table of Contents

(b)	In fiscal 2018, the Company’s consolidated subsidiary BlockSafe, issued promissory notes in exchange for cash. The notes are unsecured, bearing interest at a rate of 8% per annum, and matured in September 2019. At December 31, 2020, the outstanding balance of the notes payable amounted to $475,000.

	During the six months ended June 30, 2021, $45,000 of the notes were paid, and a note holder agreed to exchange $100,000 of notes payable for 460,829 shares of the Company’s common stock with a fair value of $88,000 (see Note 10). As a result, the Company recognized a gain on extinguishment of debt of $12,000 to account the difference between the note payable settled and fair value of the common stock issued.

	At June 30, 2021, the outstanding balance of the notes payable amounted to $330,000 and are deemed in default.

(c)	On April 7, 2020, the Company was granted a loan (the “PPP loan”) ~~from Chase Bank in the aggregate amount~~ of ~~$313,212,~~$313,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act. The PPP loan ~~agreement is dated April 7, 2020,~~ matures on April 7, 2022, bears interest at a rate of 1% per annum, with the first six months of interest deferred, is payable monthly commencing on October 2020, and iswas unsecured and guaranteed by the U.S. Small Business Administration (“SBA”). The loan term may be extended to April 7, 2025, if mutually agreed to by the Company and lender. ~~The Company applied ASC 470,~~ ~~Debt,~~ ~~to account for the PPP loan.~~ The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties. Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. ~~The Company intends to use the entire loan amount for qualifying expenses.~~ Under the terms of the PPP, certain amounts of the loan may be forgiven if they are used for qualifying expenses. As of December 31, 2020, outstanding balance of the PPP loan amounted to $313,000.

	In March 2021, the Company obtained a similar PPP loan of $177,000.

	In June 2021, the April 2020 PPP loan of $313,000 was forgiven by the SBA. Pursuant to ASC 470, Debt, the Company recorded a gain of $317,000 to extinguish the PPP loan and accrued interest of $4,000.

	As of June 30, 2021, outstanding balance of the PPP loan amounted to $177,000. The Company intends to apply for forgiveness of the PPP loan with respect to these qualifying expenses, however, the Company cannot assure that such forgiveness of any portion of the PPP loan will occur. As for the potential loan forgiveness, once the PPP loan is, in part or wholly, forgiven and a legal release is received, the liability would be reduced by the amount forgiven and a gain on extinguishment would be recorded. The terms of the PPP loan provide for customary events of default including, among other things, payment defaults, breach of representations and warranties, and insolvency events. The Company was in compliance with the terms of the PPP loan as of June 30, 2020.

~~Table of Contents~~


(d)	On May 15, 2020, the Company received a $150,000 loan (the “EID Loan”) from the SBA under the SBA’s Economic Injury Disaster Loan program. The EID Loan has a thirty-year term and bears interest at a rate of 3.75% per annum. Monthly principal and interest payments of $0.7 per month are deferred for twelve months and ~~commence~~commenced in ~~May~~June 2021. The EID Loan may be prepaid at any time prior to maturity with no prepayment penalties. The proceeds from the EID Loan must be used for working capital. The EID Loan contains customary events of default and other provisions customary for a loan of this type. The Company was in compliance with the terms of the EID loan as of June 30, ~~2020.~~2021.

	(e)	~~At December 31,~~In fiscal 2019 ~~secured notes payable totaled $271,550. During the six months ended June 30,~~and 2020, the Company issued ~~two~~ notes payable aggregating ~~$158,408,~~$468,000. The notes bear interest at a rate starting from 8% to 148% per annum, each agreement secured by substantially all of ~~which $79,949 was received through June 30, 2020. In addition, during~~ the ~~six months ended June 30, 2020,~~assets of the Company, maturing between March 2020 and July 2021. The Company also made principal payments of ~~$146,639 on the secured notes payable,~~$319,000, and one secured note ~~aggregating~~of $21,000 was extinguished as part of a debt settlement obligation ~~transaction (see Note 8).~~transaction. At ~~June 30,~~December 31, 2020, the outstanding balance of the secured note ~~payables~~agreements was ~~$186,860. The notes bear interest at 8% to 148% per annum, each agreement is secured by substantially all of the assets of the Company, and the notes mature through April 2021.~~ $128,000.

	During the six months ended June 30, ~~2020, $64,247~~2021, the Company made principal payments of ~~interest was accrued, $40,850~~$93,000.

	At June 30, 2021, the outstanding balance of ~~interest was paid on~~ the secured notes payable was $35,000. One note ~~payables and $8,400~~for $5,000 was ~~extinguished as part of a debt settlement obligation transaction (see Note 8). Two notes for $28,714 were~~ due in ~~April~~July 2020 and ~~were not repaid in full when~~is past due. The Company and the note holders are in negotiations to extend the due ~~dates~~date of the ~~loans.~~note.

Table of Contents

Note 5 - Notes Payable –- Related Parties

AtNotes payable-related parties notes represent notes payable to the Company’s Chief Executive Officer ranging in interest rates of 0% per annum to 10% per annum. The notes are unsecured and the outstanding balance of these notes payable at December 31, ~~2019,~~2020 amounted to $952,000.

During the six months ended June 30, 2021, the Company made payments of $259,000.

At June 30, 2021, the balance of notes payable-related parties totaled $742,513. During the six months ended June 30, 2020, the Company issued one note payable for $10,000 to its Chief Executive Officer. At June 30, 2020, the balance of notes payable-related parties totaled $752,513. The notes$693,000 which are ~~made up of nineteen notes payable~~all due to the Company’s Chief Executive ~~Officer, are non-interesting bearing or bear interest at rates ranging from 8% per annum to 10% per annum, are unsecured, and~~Officer. The notes are due on December 31, ~~2020.~~

At December 31, 2019, accrued interest due for the notes was $760,024. During the six months ended June 30, 2020, interest of $27,963 was accrued. At June 30, 2020, accrued interest due for the notes was $787,987. 2021.

Note 6 –- Financing Obligation

~~At December 31, 2019 and June 30, 2020,~~The Company is in the process of developing Coins or Tokens which are an envisioned virtual currency. In fiscal 2018, the Company’s consolidated subsidiary ~~BST, had recorded~~BlockSafe (BST), issued promissory notes to unrelated parties aggregating $776,000. As part of issuance, the Company agreed to pay a financing obligation to the note holders equal to the note principal in tokens, as defined, to be issued by BlockSafe. In addition, the Company also agreed to issue tokens to an unrelated party in exchange for cash of $50,000. .

During the year ended December 31, 2019, BlockSafe agreed to issue tokens to unrelated parties in exchange for cash of $122,000. In addition, certain note holders of promissory notes issued by BlockSafe agreed to exchange $315,000 of outstanding principal and accrued interest into the financing obligation to be paid by tokens to be issued by BlockSafe.

At June 30, 2021 and December 31, 2020, the outstanding balance of financing obligations amounted to $1,263,000, respectively, to be paid in tokens, as defined. At June 30, ~~2020~~2021 and through the date of filing, BST has not developed or issued any tokens and there is no assurance as to whether, or at what amount, or on what terms, tokens will be available to be issued, if ever. At June 30, ~~2020,~~2021, as the tokens do not exist, and any amounts received for tokens are not considered equity or revenue, management determined that 100% of the obligation of ~~$1,263,200~~$1,263,000 is a liability to be settled by BST, through the issuance of tokens, or through other means if tokens are never issued.

Note 7 –- Contingent Payment Obligation

On September 6, 2017, the Company entered into a litigation funding agreement with Therium Inc. (subsequently Therium Luxembourg) and VGL Capital, LLC (collectively the “Funders”). Under the agreement, the Company received $1,500,000 from the Funders to allow the Company to pursue patent enforcement actions against infringements of its ~~patents (see Note 12).~~patents. In exchange, the Funders are entitled to receive, after the payment of legal fees, the first $1,500,000 from the gross proceeds of any claims awarded, 10% of any additional claim proceeds until the Funders have received an additional $7,500,000, and 2.5% of any claim proceeds thereafter. The Funders shall be paid only in the event that the Company achieves recoveries of claim proceeds.

At June 30, 2021 and December 31, ~~2019 and June 30,~~ 2020, the Company has reflected the $1,500,000 received from the Funders as a contingent payment obligation to be paid only if claim proceeds are recovered.

Note 8 ~~– Debt Settlement Obligation~~

On May 13, 2020, the Company entered into a settlement agreement with Continuation Capital, Inc (“Continuation”). Continuation agreed to pay $197,738 owed to Company creditors, including $139,712 of convertible debt and accrued interest due to a related party (see Note 3), $29,400 of secured notes payable and accrued interest (see Note 4) and $28,626 of accounts payable. In exchange, the Company agreed to issue shares of its common stock to Continuation as consideration for the extinguishment of the debt, accrued interest, and accounts payables. The shares to be issued will be determined at a discount based on 45% of the lowest closing price of the Company common stock for the 30 trading days prior to the date of any issuance for payment. The Company determined that the settlement agreement with Continuation was a contract to settle debt with a variable number of shares based on a fixed monetary amount known at inception, and in accordance with ASC 480-10, the obligation was measured at fair value. The Company determined the fair value of the settlement obligation was $360,000 and recorded this as a liability. During the six months ended June 30, 2020, the Company issued 444,459 shares of its common stock to Continuation for the payment of $72,000 of the settlement obligation. At June 30, 2020, the balance of the debt settlement obligation liability was $288,000.

When the Company initially recorded the obligation, the difference between the $360,000 fair value and $197,738 of debt and accounts payables assumed by Continuation was recorded as a loss on extinguishment of debt of $162,262 The fair value of the 444,459 shares issued for payment of $72,000 of the settlement obligation was determined to be $98,000 based on the closing price of the shares on the date issued, and the difference of $26,000 was recorded as interest expense. As part of the transaction, the Company also issued 90,909 shares of common stock to Continuation as a fee. The fair value of the shares issued for fees was determined to be $18,182 and is included in general and administrative expenses.

~~Table of Contents~~

~~Note 9 –~~- Derivative Financial Instruments

~~At June 30, 2020,~~In prior years, the Company ~~had~~issued convertible ~~promissory~~ notes ~~outstanding that are convertible into~~payable whose conversion shares ~~of common stock of~~were not explicitly limited. As a result, the Company atwas unable to conclude that it had enough authorized and unissued shares available to settle the option of the holders at price per share discounts ranging from 20% to 62% of the Company’s common stock market price, as defined in the note agreements. As the ultimate determination of shares to be issued upon conversion ~~of these notes could exceed the current number of available authorized shares, the Company determined~~option. The result was that the conversion features of the convertible notes were not considered indexed to the Company’s own stock and characterized the fair value of the conversion features as derivative liabilities. Accordingly, the conversion features of the notes were separatedoption was bifurcated from the debt host ~~contracts (i.e. the notes)~~ and ~~characterized~~accounted for as a derivative ~~liabilities to be~~liability in accordance with ASC 815, and re-measured at the end of every reporting period with the change in value reported in the statement of operations. Furthermore, since the number of shares to be issued to settle the conversion option was potentially unlimited, the Company would be unable to conclude that it has sufficient authorized and available shares to satisfy other commitments to issue shares if it did not have a sequencing policy. The Company has not adopted, documented and disclosed a sequencing approach that allows its other equity linked financial instruments and conversion options to be classified as equity if they meet the requirements of ASC 815.

At December 31, 2019, the balance of the derivative liabilities was $1,516,435. During the six months ended June 30, 2020, the Company recorded additions of $535,000 related to the conversion features of notes issued during the period (see Note 3), and a decrease in fair value of derivatives of $212,435. In addition, the Company recorded a decrease inThe derivative liability ~~of $855,000 related to derivative liabilities that were extinguished when the related convertible note payable~~ was ~~converted into shares of common stock (see Notes 3 and 11). At June 30, 2020, the balance of the derivative liabilities was $984,000.~~

~~At June 30, 2020, the fair value of the Company’s embedded derivatives were estimated~~valued using ~~the~~a Monte Carlo ~~simulation model, which~~valuation method through the assistance of a valuations specialist. The Monte Carlo valuation method uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the conversion features, and future dividends. The Monte Carlo method is used in corporate finance and mathematical finance to value and analyze (complex) instruments, portfolios and investments by simulating the various sources of uncertainty affecting their value, and then determining the distribution of their value over the range of resultant outcomes. This is usually done by help of stochastic asset models. At December 31, 2020, the balance of the derivative liabilities was $163,000.

During the six months ended June 30, 2021, the corresponding convertible notes payable were converted to equity (see Note 2 and 10). Pursuant to current accounting guidelines, the Company determined the fair value of the derivative liability one last time which amounted to $382,000 and as a result, the Company recorded a change in fair value of $219,000. The Company also extinguished the derivative liability of $382,000 as part of loss on debt extinguishment in accordance with current accounting guidelines. At June 30, 2021, the Company has no more instruments accounted as derivative liabilities.

Table of Contents

The fair value of the embedded derivative was determined using the following average assumptions:

	June 30, 2020			January 2020 to June 2020 (dates of inception)			December 31, 2019			January 2021 to June 2021			December 31, 2020
Conversion feature:
Risk-free interest rate		0.16	%		0.11%-0.17	%		1.59	%		0.08	%		0.09	%
Expected volatility		166	%		152%-166	%		145%-155	%		424	%		495%-691	%
Expected life (in years)		1 year			1 year			0.25 to 1 year			0.41 year			0.25 to 0.57 year
Expected dividend yield		-			-			-			-			-

Fair Value:
Conversion feature	$	984,000		$	535,000		$	1,516,435		$	382,000		$	163,000

The risk-free interest rate was based on rates established by the Federal Reserve Bank. The expected volatility is based on the historical volatility of the Company’s stock. The expected life of the conversion feature of the notes was based on the remaining terms of the related notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends to its common stockholders in the past and does not expect to pay dividends to its common stockholders in the future.

The following table sets forth a summary of the changes in the estimated fair value of our embedded derivative during the six months ended June 30, ~~2020~~2021 and ~~2019:~~2020:

	Six months ended June 30, 2020			Six months ended June 30, 2019			Six months ended June 30, 2021			Six months ended June 30, 2020
Fair value at beginning of period	$	1,516,435		$	1,313,904		$	163,000		$	1,516,000
Recognition of derivative liabilities upon initial valuation		535,000			920,558			0			535,000
Extinguishment of derivative liabilities		(855,000	)		(678,692	)		(382,000	)		(855,000	)
Net change in the fair value of derivative liabilities		(212,435	)		681,710			219,000			(212,000	)
Fair value at end of period	$	984,000		$	2,237,480		$	0		$	984,000

~~Table of Contents~~

Note 109 - Operating Lease

In January 2019, the Company entered into a noncancelable operating lease for its headquarters office requiring payments of ~~$4,409~~approximately $4,000 per month, payments increasing 3% each year, and ending on January 31, 2024. ~~At June 30, 2020,~~We determine if an arrangement is a lease at inception. Lease assets are presented as operating lease right-of-use assets and the ~~remaining~~related liabilities are presented as lease ~~term was 3.58 years. The Company does not have any other leases.~~liabilities in our consolidated balance sheets pursuant to ASC 842, Leases.

Operating lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The operating lease ROU asset includes any lease payments made and excludes lease incentives.

The components of lease expense and supplemental cash flow information related to leases for the period are as follows:

Six months
ended
June 30,
2020

Six months
ended
June 30,
2019

Lease Cost

Operating lease cost (included in general and administration in the Company’s unaudited condensed statement of operations)

$ 28,092

$ 27,727

Other Information

Cash paid for amounts included in the measurement of lease liabilities for the six months ended June 30, 2020

$ 27,118

$ 26,457

Weighted average remaining lease term – operating leases (in years)

3.6

4.6

Average discount rate – operating leases

10.0 %

10.0 %

	Six months ended June 30, 2021			Six months ended June 30, 2020
Lease Cost
Operating lease cost (included in general and administration in the Company’s statement of operations)	$	28,000		$	28,000

Other Information
Cash paid for amounts included in the measurement of lease liabilities for the six months ended June 30, 2021 and 2020	$	25,000		$	27,000
Weighted average remaining lease term - operating leases (in years)		2.6			3.8
Average discount rate - operating leases		10.0	%		10.0	%

Table of Contents

The supplemental balance sheet information related to leases for the period is as follows:

	At June 30, 2020		At June 30, 2021
Operating leases
Long-term right-of-use assets	$	181,755	$	132,000

Short-term operating lease liabilities	$	48,724	$	39,000
Long-term operating lease liabilities		137,275		99,000
Total operating lease liabilities	$	185,999	$	138,000

Maturities of the Company’s lease liabilities are as follows:

Year Ending	Operating Leases			Operating Leases
2020 (remaining 6 months)	$	27,251
2021		56,000
2021 (remaining 6 months)					28,000
2022		57,680			58,000
2023		59,410			59,000
2024		4,963			5,000
Total lease payments		205,304			150,000
Less: Imputed interest/present value discount		(19,305	)		(13,000	)
Present value of lease liabilities	$	185,999		$	137,000

Lease expenses were ~~$28,092~~$28,000 and ~~$27,727~~$28,000 during the six months ended June 30, 2021 and 2020, ~~and 2019,~~ respectively.

~~Table of Contents~~

Note ~~11 –~~10 - Stockholders’ Deficit

Common Stock

During the six months ended June 30, ~~2020,~~2021, the Company issued an aggregate of ~~3,458,678~~157,906,140 shares of its common stock as follows:

	·•	~~The~~During the period ended June 30, 2021, pursuant to our offering under Regulation A, the Company issued ~~98,880~~65,866,450 shares of ~~its~~ common stock in exchange for ~~services, valued at $20,022.~~cash of $2,767,000, net of direct fees and commission.

	·•	~~Convertible note holders converted $630,360~~The Company issued 701,711 shares of ~~principal and $54,650~~its common stock for services, with a fair value of ~~accrued interest into 2,914,883~~$57,000. The common shares were valued at the respective date of issuances. Included in this issuance was 500,000 shares of common stock ~~at conversion prices ranging from $0.06 to $0.95 per share,~~ with a ~~total~~ fair value of ~~$1,517,702~~$36,000, for the purchase of a complimentary business, Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, the Company also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to the regulations of the Securities and Exchange Commission.

	•	The Company issued 16,168,589 shares of common stock upon conversion of convertible notes payable and accrued interest (see Note 2).

	·•	~~A funder converted a settlement liability of $72,000 into 444,459~~The Company issued 460,829 shares of common stock atupon conversion ~~prices ranging from $0.0825 to $0.11 per share, with a total fair value~~ of ~~$98,000~~debt settlement (see Note 8)4).

Warrants

In January 2020, in connection with the issuance of one convertible note that aggregated $75,000 (See Note 2), the Company issued warrants to purchase 50,000 shares of the Company’s common stock. The warrants were exercisable immediately, at an exercise price of $0.75 per share, and expire in 5 years. The warrants are classified within stockholders’ deficit, and the proceeds were allocated between the convertible note and warrants based on their relative fair value. The relative fair value of the warrants was determined to be $37,500 and was recorded as debt discount and additional paid-in-capital.

The table below summarizes the Company’s warrant activities for the six months ended June 30, ~~2020:~~2021:

	Number of Warrant Shares		Exercise Price Range Per Share		Weighted Average Exercise Price		Number of Warrant Shares			Exercise Price Range Per Share		Weighted Average Exercise Price

Balance, January 1, 2020		100,575	$	0.75-2.90	$	1.1185
Balance, January 1, 2021								27,405,475		$	0.0045-2.90	$	0.013132
Granted		50,000		0.75		0.75		-			-		-
Canceled/Expired		-		-		-		(90,909	)		-		-
Exercised		-		-		-		(13,333,333	)		-		-
Balance outstanding, June 30, 2020		150,575	$	0.75-2.90	$	0.996
Balance outstanding, June 30, 2021								13,981,234		$	0.0045-2.90	$	0.013132

Balance exercisable, June 30, 2020		150,575	$	0.75-2.90	$	0.996
Balance exercisable, June 30, 2021								13,981,234		$	0.0045-2.90	$	0.013132

Table of Contents

During the six months ended June 30, 2021, pursuant to the terms of the warrant grant, 13,333,333 warrant shares were exercised on a cashless basis in exchange for 12,349,726 shares of common stock. In addition, 90,909 warrant shares granted to a financing entity in fiscals 2019 and 2020 as part of a financing transaction was exercised. As a result of the exercise, the Company issued 45,150,500 shares of common stock with a fair value of $6,569,000. The common shares issued were valued at the date of issuance and recorded as a finance cost.

At June 30, ~~2020, the~~2021, intrinsic value of the warrants ~~was $175,575.~~amounted to $586,000.

The following table summarizes information concerning outstanding and exercisable warrants as of June 30, ~~2020:~~2021:

Warrants Outstanding and Exercisable

Range of Exercise Prices

Number Outstanding

Average Remaining Contractual Life (in years)

Weighted Average Exercise Price

$ 0.75

133,333

5.00

$ 0.75

$ 2.90

17,242

5.00

$ 2.90

$
0.75 - $2.90

150,575

5.00

$ 0.996

~~Table of Contents~~

		Warrants Outstanding and Exercisable
Range of Exercise Prices		Number Outstanding		Average Remaining Contractual Life (in years)		Weighted Average Exercise Price

$	0.0045		13,349,242		4.00	$	0.0045

$	0.085		588,235		4.00	$	0.085

$	0.75		26,515		3.00	$	0.75

$	2.90		17,242		3.00	$	2.90

$	0.0045 - $2.90		13,981,234		4.00	$	0.013132

Note 1211 - ~~Stock-Based Compensation~~Stock Options

At June 30, 2020, the Company had options exercisable into 633,000 shares of the Company’s common stock, with remaining estimated lives of approximately eight years. The options had been issued in 2017 and 2019 with a total fair value of approximately $475,000. The options have exercise prices generally ranging from $2.05 to $3.10 per share, and the fair value of the options is amortized over vesting terms which ranged from three to six months.

For the six months ended June 30, 2020 and 2019, the Company recognized compensation costs of $216,426 and $1,912, respectively, related to the fair value of vested options. At June 30, 2020, there was no unamortized fair value of options to be recognized as compensation in future periods.

The table below summarizes the Company’s stock option activities for the ~~period January 1, 2020 to~~six months ended June 30, ~~2020:~~2021:

	Number of Options Shares		Exercise Price Range Per Share		Weighted Average Exercise Price		Number of Options Shares			Exercise Price Range Per Share		Weighted Average Exercise Price

Balance, January 1, 2020		633,000	$	2.05-3.125	$	2.93
Balance, January 1, 2021								58,133,001		$	0.005-1,121,250,000	$	0.03704

Granted		-		-		-		-			-		-
Exercised		-		-		-		(17,500,000	)	$	0.005	$	0.005
Expired		-		-		-		-			-		-
Balance outstanding, June 30, 2020		633,000	$	2.05-3.125	$	2.93
Balance exercisable, June 30, 2020		633,000	$	2.05-3.125	$	2.93
Balance outstanding, June 30, 2021								40,633,001		$	0.005-1,121,250,000	$	0.05084
Balance exercisable, June 30, 2021								40,633,001		$	0.005-1,121,250,000	$	0.05084

Table of Contents

At June 30, ~~2020,~~2021, the intrinsic value of outstanding options was ~~zero.~~$1,940,000.

In February 2021, 12,250,000 unvested options granted in fiscal 2020 were modified and such options became fully vested. Pursuant to current accounting guidelines, the Company remeasured the fair value of these options and determined their fair value to be $3,675,000 and was recorded as stock compensation expense.

During the period ended June 30, 2021, the Company recorded additional stock compensation expense of $2,712,000 to account for options granted in the prior year that vested. In addition, the Company also issued 17,208,335 shares of the Company’s common stock upon cashless exercise of 17,500,000 options.

The following table summarizes information concerning the Company’s stock options as of June 30, ~~2020:~~2021:

Options Outstanding

Options Exercisable

Range of Exercise Prices

Number Outstanding

Average Remaining Contractual Life (in years)

Weighted Average Exercise Price

Number Exercisable

Average Remaining Contractual Life (in years)

Weighted Average Exercise Price

$ 2.85

126,000

10.00

$ 2.85

126,000

10.00

$ 2.85

$ 2.05

115,000

10.00

$ 2.05

115,000

10.00

$ 2.05

$ 3.125

392,000

10.00

$ 3.125

392,000

10.00

$ 3.125

$
0.0041 - 975,000,000

633,000

10.00

$ 2.93

633,000

10.00

$ 2.93

~~Table of Contents~~

		Options Outstanding						Options Exercisable
Range of Exercise Prices		Number Outstanding		Average Remaining Contractual Life (in years)		Weighted Average Exercise Price		Number Exercisable		Average Remaining Contractual Life (in years)		Weighted Average Exercise Price

$	1,121,250,000		1		2	$	1,121,250,000		1		2	$	1,121,250,000
$	0.005		40,000,000		10	$	0.005		40,000,000		10	$	0.005
$	2.85		126,000		7	$	2.85		126,000		7	$	2.85
$	2.05		115,000		9	$	2.05		115,000		9	$	2.05
$	3.125		392,000		6	$	3.125		392,000		6	$	3.125
$	0.0041 - 975,000,000		40,633,001		6.8	$	0.05084		40,633,001		6.8	$	0.05084

Note 1312 - ~~Commitments and Contingencies~~

~~Legal Proceedings~~

On June 20, 2016, we initiated additional patent litigation against three major competitors in the U.S. District Court for the District of New Jersey, for infringement of United States Patent No. 8,484,698. On March 14, 2017, one of the parties initiated an inter partes review (IPR) (a procedure for challenging the validity of a United States patent before the United States Patent and Trademark Office) against our second Patent No. 8,484,698. In October 2019, the litigation against the remaining two parties was dismissed. Management is currently considering its options regarding the remaining two parties.

On March 14, 2017, we initiated additional patent litigation against two major competitors in the U.S. District Court for the District of Massachusetts, for infringement of United States Patent Nos. 7,870,599, 8,484,698 and 8,713,701. Management is currently considering its options regarding the litigation.

On March 14, 2017, the Company initiated additional patent litigation against two major competitors in the U.S. District Court for the Eastern District of Virginia, for infringement of United States Patent Nos. 7,870,599, 8,484,698 and 8,713,701. On June 13, 2017, one of the competitors initiated a lawsuit against the Company in the U.S. District Court for the District of New Jersey for patent infringement (which the Company believe is without merit and will defend vigorously). This litigation is ongoing.

~~Asset Sale and Licensing Agreement~~

On August 24, 2015, the Company entered into an agreement with Cyber Safety, Inc., a New York corporation (“Cyber Safety”) for Cyber Safety to license, and retain an option to purchase, the patents and intellectual property related to the GuardedID® and MobileTrust® software. Cyber Safety had the option to buy the Company’s GuardedID® patent for $10,000,000 that expires on September 30, 2021. If the purchase price is not paid by September 30, 2021, it will increase to $11,000,000 and be due September 30, 2022. The Company anticipates, but cannot guarantee, Cyber Safety will complete the purchase by September 30, 2021. Cyber Safety also licensed the Malware Suite until September 30, 2020 and agreed to pay the Company 15% to 20% of the net amount Cyber Safety receives from this product. During the six months ended June 30, 2020 and 2019, the Company recorded revenue of $0 and $280,000, respectively, from Cyber Safety.

~~Note 14 –~~ Subsequent Events

Subsequent to June 30, ~~2020,~~2021, the Company issued three unsecured convertible promissory notes aggregating $159,500, bearing interest at 8% per annum, and maturing in twelve months through July 2021. At the option of the holder, the notes are convertible into77,155 shares of common stock for services with a fair value of the Company at a price per share discount of 61% to 70% of the market price of the Company’s common stock, as defined, for 15 to 20 days preceding a conversion notice. In July 2020, in connection with the issuance of one convertible note that aggregated $25,000, the Company issued warrants to purchase 588,235 shares of the Company’s common stock. The warrants were exercisable immediately, at an exercise price of $0.085 per share, and expire in 5 years.$4,000.

Subsequent to June 30, ~~2020, convertible notes aggregating $132,901 of principal and $7,618 of accrued interest were converted into 3,841,085~~2021, the Company issued 13,557,693 shares of common stock ~~at conversion prices ranging from $0.0214 to $0.061938 per share.~~upon cashless exercise of 15,000,000 options.

Subsequent to June 30, ~~2020,~~2021, the Company issued ~~2,680,000~~3,700,000 shares of its common stock ~~with a fair value~~to investors for cash proceeds of ~~approximately $250,000~~$176,000, net of fees and commission, pursuant to ~~pay off approximately $137,000 of~~ the ~~debt settlement obligation.~~May 2021 registered Offering Circular.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Included in this interim report are ~~“forward-looking”~~"forward-looking" statements, within the meaning of the Private Securities Litigation Reform Act of 1995 ~~(“PSLRA”~~("PSLRA") as well as historical information. Some of our statements under ~~“Business”~~"Business”, ~~“Properties”~~"Properties”, ~~“Legal~~"Legal Proceedings”, ~~“Management’s~~"Management's Discussion and Analysis of Financial Condition and Results of Operations”,”" the Notes to Condensed Consolidated Financial Statements” and elsewhere in this report constitute ~~“forward-looking statements”~~"forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that the expectations reflected in these forward-looking statements will prove to be correct. Our actual results could differ materially from those anticipated in forward-looking statements as a result of certain factors, including matters described in the section titled ~~“Risk~~"Risk Factors.”" Forward-looking statements include those that use forward-looking terminology, such as the words ~~“anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “project,” “plan,” “will,” “shall,” “should,”~~"anticipate," "believe," "estimate," "expect," "intend," "may," "project," "plan," "will," "shall," "should," and similar expressions, including when used in the negative. Although we believe that the expectations reflected in these forward-looking statements are reasonable and achievable, these statements involve risks and uncertainties and we cannot assure you that actual results will be consistent with these forward-looking statements. We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.

Such risks include, among others, the following: international, national and local general economic and market conditions: our ability to sustain, manage or forecast our growth; material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the implications and consequences of the COVID-19 pandemic on our business and on our clients’ business and on the effectiveness and distributions of recently announced vaccines, domestically and internationally to limit the impact of COVID-19, and changes to mask mandate policies; the ability to attract and retain qualified personnel; rules and regulation related to cryptocurrency, both domestic and foreign; liquidity of cryptocurrency; the development of the cryptocurrency market; international regulations on cryptocurrency; impact and marketplace perception as a result of enforcement matters promulgated by the Securities and Exchange Commission against bad actors in the cryptocurrency field and policy papers by the Securities and Exchange Commission on cryptocurrency; the ability to protect technology; and other factors referenced in this filing.

Consequently, all the forward-looking statements made in this Form 10-Q are qualified by these cautionary statements and there can be no assurance that the actual results anticipated by management will be realized or, even if substantially realized, that they will have the expected consequences to or effects on our business operations. We undertake no obligation to update or revise these forward-looking statements, whether to reflect events or circumstances after the date initially filed or published, to reflect the occurrence of unanticipated events or otherwise.

Unless otherwise noted, references in this Form 10-Q to “StrikeForce”, “we”, “us”, “our”, “SFT”, “our company”, and the “Company” means StrikeForce Technologies, Inc., a Wyoming corporation.

Background

We are a software development and services company that offers a suite of integrated computer network security products using proprietary technology. Our ongoing strategy is developing and marketing our suite of network security products to the corporate, financial, healthcare, legal, government, technology, insurance, e-commerce and consumer sectors. We plan to continue to grow our business primarily through our expanding sales channel and internally generated sales, rather than by acquisitions. ~~Apart from our~~We hold a 49% ~~holding~~interest in BlockSafe Technologies, Inc., and, as of April 2021 of this quarter, we ~~have no other subsidiaries.~~hold a 100% interest in Cybersecurity Risk Solutions, LLC.

Table of Contents

In March 2020, the World Health Organization declared the spread of COVID-19 a pandemic. This outbreak continues to spread throughout the U.S. and around the world. As a result, authorities continue to implement numerous measures to try to contain the virus, including restrictions on travel, quarantines, shelter-in-place orders, business restrictions and complete ~~shut-downs.~~shutdowns. We are not considered an “essential business” due to the industries and customers we serve. As of, and subsequent to, June 30, ~~2020,~~2021, we have been following the recommendations of the CDC and state/local health authorities to minimize exposure risk for our team members ~~for~~during the ~~past several months,~~pandemic, including the temporary closure of our corporate office and having our team members work remotely. ~~Most~~During the second quarter of 2021, we reopened our corporate office while continuing to adhere to the guidelines issued by health authorities. Many customers and vendors have transitioned to electronic submission of invoices and payments. The COVID-19 pandemic has resulted in longer response times from potential new customers and certain existing customers. We cannot anticipate the effect that the impairments caused by the COVID-19 pandemic will have on our fiscal ~~2020 results.~~2021 results, or the effectiveness and distributions of vaccines and their distribution in 2021 and changes to mask mandate policies. The pandemic has significantly impacted the economic conditions both in the United States and worldwide, with accelerated effects through the date of this Quarterly Report, as federal, state and local governments react to the public health crisis, creating significant uncertainties in both the worldwide and the United States economies. The situation is rapidly changing, including the onset of the current fourth wave of the virus caused by the Delta variant and the possibility of other variants over time, and additional impacts to our business may arise that we are not aware of currently. We cannot predict whether, when or the manner in which, the conditions surrounding COVID-19 will change including the timing of lifting any restrictions or office closure requirements. We will continue to evaluate the nature and extent of COVID-19’s impact to our business, consolidated results of operations, financial condition and liquidity, and our results presented herein are not necessarily indicative of the results to be expected for future periods in ~~2020~~2021 or ~~the full fiscal year.~~beyond.

Management believes that cyber security is a growing requirement as the pandemic continues and more people are working remotely as well as using digital forms on a regular basis. Consequently, the market demand, in our estimation, is increasing. However, our Company is also experiencing the impact of the pandemic. Currently our management ~~is not working~~has limited business operating from our office location and this ~~impairs our ability coordinate growth and~~ impedes our ability to take full advantage of the increasing market demand. Instead, like many businesses, we are focused in maintaining our business, in contrast to the prior business plan of continued growth. Most, if not all, of our business continues from home where it is difficult to operate under normal conditions. Many of our current clients ~~also~~ have experienced a dramatic slowdown in their business, limiting their ability to have the resources to pay for our services. We still produce revenues and we anticipate, but cannot guarantee, ~~we will have the resources to advance~~ our video conferencing tool, ~~that will we believe will provide~~SafeVchat™, which provides authentication and ~~encryption~~security (using our ~~products already built)~~existing products), ~~for which we believe~~ will have ~~a great interest~~gained acceptance in the market. Currently, we have companies ~~already interested in~~doing beta testing. During the six months ended June 30, 2021, we earned revenues of $36,000 from SafeVchat™ and PrivacyLoK™ and overall revenues of $113,000. We believe, but cannot guarantee, that our ~~beta that we~~sales, partly as a consequence of the new work environment created by the pandemic and the need for our products, will ~~be starting~~significantly increase in the ~~fourth quarter~~remainder of ~~2020.~~2021 and continue that substantial growth into 2022.

On November 13, 2020, our filing of an Offering Circular on Form 1-A, pursuant to Regulation A (File Number: 024-11267) was qualified by the Securities and Exchange Commission. We registered 668,449,198 shares of common stock for maximum proceeds of $2,315,000 (after deducting the maximum broker discount and costs of the offering). As of June 30, 2021, the offering was fully subscribed as we accepted the subscriptions for an aggregate of 474,453,653 shares of common stock for full satisfaction of the entire offering of $2,500,000 (of which we received $2,315,000). We announced the closing of the offering on our Current Report on Form 8-K as filed on February 8, 2021.

On May 11, 2021, our filing of an Offering Circular on Form 1-A, pursuant to Regulation A (File Number: 024-11512) was qualified by the Securities and Exchange Commission. We registered 150,000,000 shares of common stock for maximum proceeds of $7,065,000 (after deducting the maximum broker discount and costs of the offering). During the six months ended June 30, 2021, we issued 27,750,000 shares of common stock to investors for cash proceeds of $1,318,000, net of fees and commission, pursuant to the May 2021 Offering Circular. Subsequent to June 30, 2021, we issued 3,700,000 shares of common stock to investors for cash proceeds of $176,000, net of fees and commission, pursuant to the May 2021 Offering Circular.

We finished development of our SafeVchat™ Secure Video Conferencing and PrivacyLoK™ products at the end of 2020 and deployed SafeVchat™ beta testing by some by our clients and individuals through our resellers. SafeVchat™, in management’s estimation, is one of the most secure video conferencing products on the market. PrivacyLoK™ adds security to all video conferencing tools and runs in conjunction with other applications on the same computer. We anticipate, but cannot guarantee, increased revenues from SafeVchat™ and PrivacyLoK™ in 2021 and beyond.

Our executive office is located at 1090 King Georges Post Road, Suite 603, Edison, NJ 08837. Our telephone number is (732) 661-9641. We have 911 employees. Our Company’s website is www.strikeforcetech.com (we are not including the information contained in our website as part of, nor should the information be relied upon or incorporated by reference into, this report on Form 10-Q).

Table of Contents

Results of Operations

FOR THE THREE MONTHS ENDED JUNE 30, ~~2020~~2021 COMPARED TO THE THREE MONTHS ENDED JUNE 30, ~~2019~~2020

Revenues for the three months ended June 30, ~~2020~~2021 were ~~$51,000~~$67,000 compared to ~~$308,000~~$51,000 for the three months ended June 30, ~~2019, a decrease~~2020, an increase of ~~$257,000~~$16,000 or ~~83.4%~~31.4%. The ~~decrease~~increase in revenues was primarily due to revenues relating to our SafeVchat™ product, despite the impairments ~~caused by~~related to the economic consequences of the COVID-19 ~~pandemic that resulted in a decrease in our software and service revenues.~~pandemic. Revenues are derived from software, key fobs and services.

Cost of revenues for the three months ended June 30, ~~2020~~2021 was ~~$7,000~~$8,000 compared to ~~$2,000~~$7,000 for the three months ended June 30, ~~2019,~~2020, an increase of ~~$5,000,~~$1,000 or ~~250%~~14.3%. ~~The increase resulted from the increased~~Cost of revenues are fees and key fobs related to ~~certain revenues. Cost of~~our revenues, and as a percentage of total revenues for the three months ended June 30, ~~2020~~2021 was ~~12.8%~~11.9% compared to ~~0.8%~~12.8% for the three months ended June 30, ~~2019.~~2020.

Research and development expenses for the three months ended June 30, ~~2020~~2021 were ~~$124,000~~$129,000 compared to $124,000 for the three months ended June 30, ~~2019.~~2020, an increase of $5,000 or 4.8%. The increase was primarily due to the increase in salaries and benefits of the personnel conducting research and development. The salaries, benefits and overhead costs of personnel conducting research and development of our software products primarily comprises our research and development expenses.

Compensation, professional fees, and selling, general and administrative (collectively, “SGA”) expenses for the three months ended June 30, ~~2020~~2021 were ~~$539,000~~$1,820,000 compared to $379,000 for the three months ended June 30, 2019, an increase of $160,000 or 42.2%. The increase was due primarily to an increase in employee stock-based compensation and professional fees. SG&A expenses consist primarily of salaries, benefits and overhead costs for executive and administrative personnel, insurance, fees for professional services, including consulting, legal, and accounting fees, plus travel costs and non-cash stock compensation expense for the issuance of stock options to employees and other general corporate expenses.

~~Table of Contents~~

For the three months ended June 30, 2020, other expense was $547,000 as compared to other expense of $986,000 for the three months ended June 30, 2019, representing a decrease in other expense of $439,000, or 44.5%. The decrease was primarily due to increases in the change in the fair value of derivative liabilities and decreases in private placement costs and debt discount amortization, offset by an increase in the loss on extinguishment of debt.

~~Our net loss~~$538,000 for the three months ended June 30, 2020, was $1,165,000 compared to $1,183,000 for the three months ended June 30, 2019, a decrease of $18,000, or 1.5%. The decrease was primarily due to increases in employee stock-based compensation and professional fees, the change in the fair value of derivative liabilities, and decreases in private placement costs and debt discount amortization, the decrease in revenues and an increase in the loss on extinguishment of debt.

~~FOR THE SIX MONTHS ENDED JUNE 30, 2020 COMPARED TO THE SIX MONTHS ENDED JUNE 30, 2019~~

Revenues for the six months ended June 30, 2020 were $111,000 compared to $439,000 for the six months ended June 30, 2019, a decrease of $328,000 or 74.7%. The decrease in revenues was primarily due to impairments caused by the COVID-19 pandemic that resulted in a decrease in our software and service revenues. Revenues are derived from software, key fobs and services.

~~Cost of revenues for the six months ended June 30, 2020 was $9,000 compared to $6,000 for the six months ended June 30, 2019,~~ an increase of ~~$3,000,~~$1,282,000 or 50.0%. The increase resulted from the increased fees related to certain revenues. Cost of revenues as a percentage of total revenues for the six months ended June 30, 2020 was 8.1% compared to 2.9% for the six months ended June 30, 2019.

Research and development expenses for the six months ended June 30, 2020 were $248,000 compared to $250,000 for the six months ended June 30, 2019, a nominal decrease of $2,000 or 1.0%. The salaries, benefits and overhead costs of personnel conducting research and development of our software products primarily comprises our research and development expenses.

Compensation, professional fees, and selling, general and administrative (collectively, “SGA”) expenses for the six months ended June 30, 2020 were $1,047,000 compared to $826,000 for the six months ended June 30, 2019, an increase of $221,000 or 26.8%238%. The increase was due primarily to an increase in employee stock-based compensation and professional fees. SG&A expenses consist primarily of salaries, benefits and overhead costs for executive and administrative personnel, insurance, fees for professional services, including consulting, legal, and accounting fees, plus travel costs and non-cash stock compensation expense for the issuance of stock options to employees and other general corporate expenses.

For the ~~six~~three months ended June 30, ~~2020,~~2021, other expense was ~~$877,000~~$3,153,000 as compared to other expense of ~~$1,855,000~~$547,000 for the three months ended June 30, 2020, an increase in other expense of $2,606,000, or 476%. The increase was primarily due to increases in financing costs, offset by decreases in debt discount amortization.

Our net loss for the three months ended June 30, 2021 was $5,043,000 compared to $1,165,000 for the three months ended June 30, 2020, an increase of $3,878,000, or 333%. The increase was primarily due to increases in employee stock-based compensation, professional fees and financing costs, offset by decreases in debt discount amortization.

FOR THE SIX MONTHS ENDED JUNE 30, 2021 COMPARED TO THE SIX MONTHS ENDED JUNE 30, 2020

Revenues for the six months ended June 30, ~~2019, representing~~2021 were $113,000 compared to $111,000 for the six months ended June 30, 2020, an increase of $2,000 or 1.8%. The increase in revenues was primarily due to revenues relating to our SafeVchat™ product, despite the impairments related to the economic consequences of the COVID-19 pandemic. Revenues are derived from software, key fobs and services.

Cost of revenues for the six months ended June 30, 2021 was $11,000 compared to $9,000 for the six months ended June 30, 2020. Cost of revenues are fees and key fobs related to our revenues, and as a ~~decrease~~percentage of total revenues for the six months ended June 30, 2021 was 9.7% compared to 8.1% for the six months ended June 30, 2020.

Research and development expenses for the six months ended June 30, 2021 were $274,000 compared to $248,000 for the six months ended June 30, 2020, an increase of $26,000 or 10.5%. The increase was primarily due to the increase in salaries and benefits of the personnel conducting research and development. The salaries, benefits and overhead costs of personnel conducting research and development of our software products primarily comprises our research and development expenses.

Compensation, professional fees, and selling, general and administrative (collectively, “SGA”) expenses for the six months ended June 30, 2021 were $7,448,000 compared to $1,047,000 for the six months ended June 30, 2020, an increase of $6,401,000 or 611%. The increase was due primarily to an increase in employee stock-based compensation and professional fees. SG&A expenses consist primarily of salaries, benefits and overhead costs for executive and administrative personnel, insurance, fees for professional services, including consulting, legal, and accounting fees, plus travel costs and non-cash stock compensation expense for the issuance of stock options to employees and other general corporate expenses.

Table of Contents

For the six months ended June 30, 2021, other expense was $7,369,000 as compared to other expense of $877,000 for the six months ended June 30, 2020, an increase in other expense of ~~$978,000,~~$6,492,000, or ~~52.7%~~740%. The ~~decrease~~increase was primarily due to increases in ~~the change in the fair value of derivative liabilities and~~financing costs, offset by decreases in private placement costs and debt discount ~~amortization, offset by increases in interest expense and the loss on extinguishment of debt.~~amortization.

Our net loss for the six months ended June 30, ~~2020~~2021 was ~~$2,070,000~~$14,989,000 compared to ~~$2,498,000~~$2,070,000 for the six months ended June 30, ~~2019, a decrease~~2020, an increase of ~~$428,000,~~$12,919,000, or ~~17.1%~~624%. The ~~decrease~~increase was primarily due to increases in employee stock-based compensation, ~~and~~ professional fees ~~the change in the fair value of derivative liabilities,~~ and financing costs, offset by decreases in private placement costs and in debt discount ~~amortization, the decrease in revenues and increases in interest expense and the loss on extinguishment of debt.~~amortization.

Liquidity and Capital Resources

Our total current assets at June 30, ~~2020~~2021 were ~~$148,000,~~$1,386,000, which included cash of ~~$122,000,~~$1,348,000, as compared with ~~$99,000~~$203,000 in total current assets at December 31, ~~2019,~~2020, which included cash of ~~$75,000.~~$162,000. Additionally, we had a stockholders’ deficit in the amount of ~~$15,644,000~~$12,428,000 at June 30, ~~2020~~2021 compared to a stockholders’ deficit of ~~$15,464,000~~$14,342,000 at December 31, ~~2019.~~2020. We have historically incurred recurring losses and have financed our operations through loans, principally from affiliated parties such as our directors, and from the proceeds of debt and equity financing. We financed our operations during the six months ended June 30, ~~2020~~2021 primarily from the ~~receipt~~sale of common shares for cash for net proceeds of $2,767,000 under the ~~SBA-Payroll~~offering pursuant to Regulation A , and we received the second draw SBA Paycheck Protection ~~Program~~assistance loan ~~funds of $313,212 and the SBA-Economic Injury Disaster Loan funds of $150,000.~~for $177,000.

Concentrations

~~Table of Contents~~

Going Concern

We have yet to establish any history of profitable operations. During the six months ended June 30, ~~2020,~~2021, the Company incurred a net loss of ~~$2,070,000~~$14,989,000 and used cash in operating activities of ~~$790,000,~~$1,271,000, and at June 30, ~~2020,~~2021, the Company had a stockholders’ deficit of ~~$15,644,000.~~$12,428,000. In addition, we are in default on notes payable and convertible notes payable in the aggregate amount of ~~$3,624,000.~~$3,407,000. These factors raise substantial doubt about our ability to continue as a going concern within one year after the date the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report published on our December 31, ~~2019~~2020 year-end financial statements, and Note 1 in our unaudited financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The Company’s financial statements do not include any adjustments that might result from the outcome of this uncertainty should we be unable to continue as a going concern.

Management estimates that the current funds on hand will be sufficient to continue operations through the next six months. Our ability to continue as a going concern is dependent upon our ability to ~~raise additional funds and~~continue to implement our business plan. ~~Management is currently seeking additional funds, primarily through the issuance of debt and equity securities for cash to operate our business.~~ Currently, management is ~~also~~ attempting to increase revenues ~~and improve gross margins~~ by ~~a revised sales strategy. We are redirecting our sales focus from direct sales to domestic and international sales channel, where we are primarily~~ selling through a channel of ~~Distributors, Value Added Resellers, Strategic Partners~~distributors, value added resellers, strategic partners and ~~Original Equipment Manufacturers.~~original equipment manufacturers. While we believe in the viability of ~~our~~its strategy to increase revenues, ~~and in our ability to raise additional funds,~~ there can be no assurances to that effect. Our ability to continue as a going concern is dependent upon our ability to ~~continually~~ increase our customer base and realize increased ~~revenues from recently signed contracts.~~revenues. No assurance can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory to us. Even if we are able to obtain additional financing, if needed, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

Reverse Stock Split and Changes in Authorized Shares

In ~~April~~December 2020, a decrease of the authorized shares of our ~~Board~~common stock from fourteen billion (14,000,000,000) to four billion (4,000,000,000), $0.0001 par value, was ratified, effective upon the filing of ~~Directors approved~~an amendment to our Certificate of Incorporation with the Wyoming Secretary of State. The amendment was adopted in December 2020.

On June 25, 2020, we completed a 1:500 reverse stock split ~~that was approved by stockholders controlling 80%~~ of our issued and outstanding shares of common ~~stock. The reverse~~ stock ~~split was effectuated on June 25, 2020~~ and all fractional shares were rounded up. All share and per share amounts onhave been adjusted retroactively to reflect the ~~accompanying financial statements are presented in post-split amounts~~reverse stock split as if ~~the split~~it had occurred at the beginning of the earliest period presented.

Table of Contents

~~In April 2020, an increase of our common stock from 12,000,000,000 to 17,000,000,000 shares was authorized.~~

Cybersecurity Risk Solutions, LLC

On April 15, 2021, StrikeForce formally closed a Member Interest Purchase Agreement in which StrikeForce acquired the entire Member Interests of Cybersecurity Risk Solutions, LLC, a New Jersey limited liability company. In April ~~2020, a decrease~~2021, we issued 500,000 shares of ~~our~~ common stock ~~from 17,000,000,000~~with a fair value of $36,000, for the purchase of Cybersecurity Risk Solutions, LLC. At the date of acquisition, Cybersecurity Risk Solutions, LLC had nominal assets and liabilities, no revenues and limited operating history. Furthermore, the Company also determined that the acquisition did not meet the requirement of a significant acquisition pursuant to ~~14,000,000,000 shares~~the regulations of the Securities and Exchange Commission.

Cybersecurity Risk Solutions, LLC is a cybersecurity firm offering cyber, privacy & data protection services including a personal cyber risk assessment, the industry’s first cyber health score, report and custom action plan, as well as ongoing vulnerability scanning, hack monitoring and dark web intelligence monitoring. For more information, go to https://SecureCyberID.com (which website is expressly not included in this filing). Will Lynch, the prior sole member of Cybersecurity Risk Solutions, LLC was ~~authorized.~~hired by StrikeForce as the Director of Channel Distribution and not as a Named Executive Officer. A Director of Channel Distribution develops, services, and grows relationships with clients. Mr. Lynch will have an annual salary of $100,000 and will also receive 2% net of all Channel sales. Mr. Lynch reports to our Executive Vice President and Marketing Director.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, result of operations, liquidity or capital expenditures.

Critical Accounting Policies

Use of Estimates

~~Table of Contents~~

Revenue Recognition

The Company’s revenue consists of revenue from sales and support of our software products. Revenue primarily consists of sales of software licenses and subscriptions of our ProtectID®, GuardedID®, MobileTrust®, PrivacyLoK™ and ~~MobileTrust®~~SafeVchat™ products. We recognize revenue from these arrangements ratably over the contractual service period. For service contracts, the Company’s performance obligations are satisfied, and the related revenue is recognized, as services are rendered.

Cost of revenue includes direct costs and fees related to the sale of our products.

Table of Contents

Share-Based Payments

The Company periodically issues stock options, warrants, and shares of common stock as share-based compensation to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on FASB ASC 718, Compensation –- Stock Compensation (Topic 718) whereby the value of the award is measured on the date of grant and recognized as compensation expense on the straight-line basis over the vesting period. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.

Derivative Financial Instruments

Recently Issued Accounting Pronouncements

Refer to Note 1 in the accompanying ~~condensed~~ consolidated financial statements.

Additional Information

You are advised to read this Form 10-Q in conjunction with other reports and documents that we file from time to time with the SEC. In particular, please read our Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K, and Current Reports on Form 8-K that we file from time to time. You may obtain copies of these reports directly from us or from the SEC at the SEC’s Public Reference Room at 100 F. Street, N.E. Washington, D.C. 20549, and you may obtain information about obtaining access to the Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains information for electronic filers at its website http://www.sec.gov.

~~Table of Contents~~

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to provide the information required by this Item.

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures.

Regulations under the Securities Exchange Act of 1934 (the “Exchange Act”) require public companies to maintain “disclosure controls and procedures,” which are defined as controls and other procedures that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange ~~Commission’s~~Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the ~~issuer’s~~issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Table of Contents

We carried out an evaluation, with the participation of our management, including our Chief Executive Officer (“CEO”) and our Chief Financial Officer (CFO) of the effectiveness our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of June 30, ~~2020.~~2021. Based upon that evaluation, our CEO and CFO concluded that our disclosure controls and procedures are not effective at the reasonable assurance level due to the following material weaknesses:

1. We do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404 of the Sarbanes-Oxley Act which is applicable to us as of and for the interim period ended June 30, ~~2020.~~2021. Management evaluated the impact of our failure to have written documentation of our internal controls and procedures on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

2. Our board of directors has no independent director or member with financial expertise which causes ineffective oversight of our external financial reporting and internal control over financial reporting.

3. We do not have sufficient segregation of duties within accounting functions, which is a basic internal control. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. However, to the extent possible, the initiation of transactions, the custody of assets and the recording of transactions should be performed by separate individuals. Management evaluated the impact of our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

To address these material weaknesses, management performed additional analyses and other procedures to ensure that the financial statements included herein fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented.

Remediation of Material Weaknesses

We intend to remediate the material weaknesses in our disclosure controls and procedures identified above by adding an independent director or member with financial expertise or hiring a full-time CFO with SEC reporting experience in the future when working capital permits and by working with our independent registered public accounting firm to refine our internal procedures.

(b) Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2526

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

On March 14, 2017, we initiated additional patent litigation against two major competitors in the U.S. District Court for the Eastern District of Virginia, for infringement of United States Patent Nos. 7,870,599, 8,484,698 and 8,713,701. This litigation is ongoing. On June 13, 2017, one of the competitors initiated a lawsuit against us in the U.S. District Court for the District of New Jersey for patent infringement (which we believe is without merit and will defend vigorously). This litigation is ongoing.

~~On December 1, 2017, The United States District Court for the Central District of California issued an opinion in the~~ ~~StrikeForce Technologies, Inc. v. SecureAuth Corp~~. case, which invalidated claims of U.S. Patent Nos. 7,870,599, 8,484,698 and 8,713,701 under 35 U.S.C. §101. We strongly disagreed with the Court’s decision and an appeal was filed by our attorney in July 2019. In October 2019, the Supreme Court of the United States denied our petition for a writ of certiorari in ~~StrikeForce Technologies, Inc. v. SecureAuth Corp (19-103).~~ Thus, the claims asserted against SecureAuth in the Central District of California, case no. 2:17-cv-04314-JAK-SK, remain invalid under 35 U.S.C. 101. Our three patents contain a total of 108 claims, 43 claims were deemed invalid, however, 65 claims are still valid. Despite the Supreme Court’s decision, our Protect ID® products still retain patent protection and our management intends to further expand those protections with new patents in the coming months. In the meantime, we continue to monitor the Federal Courts because there are several cases (i.e. Berkheimer v. HP), whereby a decision for Berkheimer could change the appellate landscape for 101 motion cases. Additionally, U.S. Senators Thom Tillis (R-NC) and Chris Coons (D-DE), along with several other Senators have released a bipartisan, bicameral draft bill that would reform Section 101 of the Patent Act in a manner we believe would be beneficial to us. Management continue guarantee that any pending claims or legislation will result in favorable decisions.

On November 4, 2019, StrikeForce Technologies, Inc. v. DUO Security Inc., Civil Action No: 2-16-cv-03571-JMV-MF which was in the District of New Jersey, was dismissed with prejudice. Each party shall bear its/their own costs.

On November 5, 2019, StrikeForce Technologies, Inc. v. Centrify Corporation, Civil Action No. 2:16-cv-03574-JMV-MF which was in the District of New Jersey, was dismissed without prejudice. Each party shall bear its/their own costs.None.

ITEM 1A. RISK FACTORS

~~As a smaller reporting company, we~~The risk factors required pursuant to Regulation S-K, Item 503(c) are not required for smaller reporting companies. Accordingly, the Company has determined to provide ~~the information required by this Item; however, the following~~particular risk factors ~~supplement~~at this time. The risks and uncertainties described below are not the only ones facing us. Other events that we do not currently anticipate or that we currently deem immaterial also may affect our ~~“Risk Factors”~~results of operations and financial condition. If any events described in the risk factors actually occur, our business, operating results, prospects and financial condition could be materially harmed. In connection with the forward looking statements that appear in our Annual Report on Form 10-K for the year ended December 31, ~~2019,~~2020, which was filed with the Securities and Exchange Commission on ~~May 1, 2020:~~April 13, 2021, you should also carefully review the cautionary statement referred to under “Special Note Regarding Forward Looking Statements.” The forward-looking statements made in this report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.

COVID-19.

We cannot, at this point, determine the extent to which COVID-19 outbreak will impact business or the economy as both are highly uncertain and cannot be predicted.

~~Table of Contents~~

THE OUTBREAK OF THE CORONAVIRUS MAY NEGATIVELY IMPACT SOURCING AND MANUFACTURING OF THE PRODUCTS THAT WE SELL AS WELL AS CONSUMER SPENDING, WHICH COULD ADVERSELY AFFECT OUR BUSINESS, RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

In December 2019, a novel strain of coronavirus was reported to have surfaced in Wuhan, China, which has and is continuing to spread throughout China and other parts of the world, including the United States. On January 30, 2020, the World Health Organization declared the outbreak of the coronavirus disease (COVID-19) a “Public Health Emergency of International Concern.” On January 31, 2020, U.S. Health and Human Services Secretary Alex M. Azar II declared a public health emergency for the United States to aid the U.S. healthcare community in responding to COVID-19, and on March 11, 2020 the World Health Organization characterized the outbreak as a “pandemic”. The significant outbreak of COVID-19 has resulted in a widespread health crisis that could adversely affect the economies and financial markets worldwide, and could adversely affect our business, results of operations and financial condition.

In addition, we applied for funding pursuant to the Small Business Administration program. The Paycheck Protection Program provides forgivable funding for payroll and related costs as well as some non-payroll costs. We applied for funding and ~~to date, have~~we received (on April 17, 2020) first draw funding in the amount of $313,000 (fully forgiven on June 10, 2021) and we received (on March 16, 2021) second draw funding in the amount of $177,000. The Economic Injury Disaster Loan provides low-interest, long-term financing. We previously applied for funding and received (on May 18, 2020) funding in the amount of ~~$313,212.~~$150,000. No assurances can be provided as to the adequacy of the funds received for ongoing operations in ~~2020~~2021 or if additional funding will be subsequently available.

Table of Contents

THE OUTBREAK OF THE COVID-19 MAY ADVERSELY AFFECT OUR CUSTOMERS.

Further, such risks as described above could also adversely affect our ~~customers’~~customers' financial condition, resulting in reduced spending for the merchandise we sell. Risks related to an epidemic, pandemic or other health crisis, such as COVID-19, could also lead to the complete or partial closure of one or more of our facilities or operations of our sourcing partners. The ultimate extent of the impact of any epidemic, pandemic or other health crisis on our business, financial condition and results of operations will depend on future developments, which are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of such epidemic, pandemic or other health crisis and actions taken to contain or prevent their further spread, among others. These and other potential impacts of an epidemic, pandemic or other health crisis, such as COVID-19, could therefore materially and adversely affect our business, financial condition and results of operations.

The economic conditions arising from the pandemic have resulted in an economy that is volatile and unpredictable. Some companies are experiencing reduced revenues and in turn, as a consequence of limited cash flow, are not prepared to purchase our products. COVID-19 has led to some of our customers and potential customers being stricken with the virus causing them to not be able to work for many weeks and therefore causing delays for us in our marketing decisions. This outbreak could decrease spending, adversely affect demand for our products, and harm our business and results of operations. It is not possible for us to predict the duration or magnitude of the adverse results of the outbreak or the timing and the degree to which economic recovery will be realized post-pandemic and, consequently, its effects on our business or results of operations, financial condition, or liquidity, at this time. We cannot anticipate the effect that the impairments caused by the COVID-19 pandemic or the degree to which the economy rebounds post-pandemic will have on the last quarters of 2021 and into 2022 results, or the effectiveness and distributions of recently announced vaccines, changes to mask mandate policies, and impact of the Delta variant and other possible future variants. We will continue to evaluate the nature and extent of COVID-19’s impact to our business, consolidated results of operations, financial condition and liquidity, and our results presented herein are not necessarily indicative of the results to be expected for future years.

THE OUTBREAK OF COVID-19 HAS RESULTED IN A WIDESPREAD HEALTH CRISIS THAT COULD ADVERSELY AFFECT THE ECONOMIES AND FINANCIAL MARKETS WORLDWIDE AND COULD EXPONENTIALLY INCREASE THE RISK FACTORS DESCRIBED IN OUR PRIOR FILINGS.

SHOULD ONE OR MORE OF THE FOREGOING RISKS OR UNCERTAINTIES MATERIALIZE, OR SHOULD THE UNDERLYING ASSUMPTIONS PROVE INCORRECT, ACTUAL RESULTS MAY DIFFER SIGNIFICANTLY FROM THOSE ANTICIPATED, BELIEVED, ESTIMATED, EXPECTED, INTENDED OR PLANNED.

ITEM 2. RECENT ISSUANCES OF UNREGISTERED SECURITIES

In April 2020, two convertible note holders converted $55,120 of principal and $6,401 of accrued interest into 371,474 shares of common stock at conversion prices ranging from $0.12 to $0.21 per share, as adjusted by our 1:500 reverse stock split adopted on June 25, 2020.

In May 2020, three convertible note holders converted $50,880 of principal and $11,443 of accrued interest into 578,641 shares of common stock at conversion prices ranging from $0.06 to $0.18 per share, as adjusted by our 1:500 reverse stock split adopted on June 25, 2020.

~~Table of Contents~~

~~In May 2020,~~2021, we issued a total of ~~90,909~~32,680 shares of restricted common stock, ~~as adjusted by our 1:500 reverse stock split adopted on June 25, 2020,~~valued at $2,000, to a ~~funder, as~~consultant for services provided relating to a ~~fee, upon execution of an agreement for the settlement of certain debt and trade payables in exchange for shares of the Company’s common stock.~~consultant agreement.

In ~~June 2020, two convertible note holders converted $76,800 of principal and $5,844 of accrued interest into 1,118,262~~April 2021, we issued 500,000 shares of common stock ~~at conversion prices ranging from $0.06 to $0.09 per share, as adjusted by our 1:500 reverse stock split adopted on June 25, 2020.~~with a fair value of $36,000, for the purchase of a complimentary business, Cybersecurity Risk Solutions, LLC.

In ~~June 2020,~~April 2021, we issued 28,219,063 shares of common stock with a fair value of $3,308,000 for financing services rendered and cancellation of warrants to purchase 56,438 shares of common stock that was granted in fiscal 2019. The common shares issued were valued at the ~~funder from the~~date of issuance.

In May ~~2020 settlement agreement processed conversions~~2021, we sold subscriptions for ~~2,680,000~~$679,000, net of fees and commission, and issued 14,300,000 shares of our common stock relating to the May 2021 registered Offering Circular.

Table of Contents

In May 2021, we issued a total of 33,004 shares of restricted common stock, valued at ~~conversion prices ranging from $0.022~~$2,000, to ~~$0.054945 per share, as adjusted by our 1:500 reverse~~a consultant for services provided relating to a consultant agreement.

In May 2021, we issued 12,349,726 shares of common stock ~~split adopted on June 25,~~with a fair value of $800,000 for financing services rendered and cancellation of warrants to purchase 12,349,726 shares of common stock that was granted in fiscal 2020. The common shares issued were valued at the date of issuance.

In June ~~2020,~~2021, we sold subscriptions for $639,000, net of fees and commission, and issued 13,450,000 shares of our common stock relating to the May 2021 registered Offering Circular.

In June 2021, we issued a total of 7,500 shares of restricted common stock, valued at ~~$328,~~$450, relating to a December 2009 retainer agreement with our SEC attorney.

InSubsequent issuances:

Subsequent to June ~~2020, our transfer agent~~30, 2021, we issued ~~456 shares of our common stock, as rounding shares related to our 1:500 reverse stock split of our issued and outstanding~~77,155 shares of common stock ~~that was adopted on~~for services with a fair value of $4,000.

Subsequent to June ~~25, 2020.~~30, 2021, we issued 13,557,693 shares of common stock upon cashless exercise of 15,000,000 options.

Subsequent to June 30, 2021, we issued 3,700,000 shares of its common stock to investors for cash proceeds of $176,000, net of fees and commission, pursuant to the May 2021 registered Offering Circular.

The above ~~offering was~~offerings, apart from the offerings registered pursuant to the Securities Act of 1933, were made in reliance upon the exemption from registration under Rule 506 of Regulation D promulgated under the Securities Act of 1933 and/or Section 4(2) of the Securities Act of 1933, based on the following: (a) the investors confirmed to us that they were “accredited investors,” as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933 and had such background, education and experience in financial and business matters as to be able to evaluate the merits and risks of an investment in the securities; (b) there was no public offering or general solicitation with respect to the offering; (c) the investors were provided with certain disclosure materials and all other information requested with respect to our company; (d) where applicable, the investors acknowledged that all securities being purchased were “restricted securities” for purposes of the Securities Act of 1933, and agreed to transfer such securities only in a transaction registered under the Securities Act of 1933 or exempt from registration under the Securities Act; and (e) where applicable, a legend was placed on the certificates representing each such security stating that it was restricted and could only be transferred if subsequent registered under the Securities Act of 1933 or transferred in a transaction exempt from registration under the Securities Act of 1933.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

At June 30, ~~2020,~~2021, the Company is in default on notes payable and convertible notes payable in the aggregate amount of ~~$3,590,000.~~$3,407,000. We have not made various principal and interest payments on many of our debt obligations. We continue to seek work-out arrangements and applicable refinancing with new or revised debt or equity instruments. See Notes 2 and 4 to the condensed consolidated financial statements.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION.

None.

2829

Table of Contents

ITEM 6. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

Exhibit Number		Description
1.1		Placement Agreement dated July 7, 2020, by and between StrikeForce Technologies, Inc. and Spencer Clarke LLC (23)
1.2		Addendum to Placement Agreement dated November 11, 2020, by and between StrikeForce Technologies, Inc. and Spencer Clarke LLC (25)
1.3		Addendum to Placement Agreement dated April 20, 2021, by and between StrikeForce Technologies, Inc. and Spencer Clarke LLC (28)
3.1		Amended and Restated Certificate of Incorporation of StrikeForce Technologies, Inc.(1)
3.2		By-laws of StrikeForce Technologies, Inc. (1)
3.3		Amended By-laws of StrikeForce Technologies, Inc. (2)
3.4		Amended By-laws of StrikeForce Technologies, Inc. (3)
3.5		Articles of Amendment of StrikeForce Technologies, Inc. (2)
3.6		Amendments to Articles of Incorporation (6)
3.7		Amendments to Articles of Incorporation (7)
3.8		Registration of Classes of Securities (8)
3.9		Amendments to Articles of Incorporation (9)
3.10		Registration of Classes of Securities (10)
3.11		Amendments to Articles of Incorporation (11)
3.12		Registration of Classes of Securities (12)
3.13		Amendments to Articles of Incorporation (13)
3.14		Amendments to Articles of Incorporation (14)
3.15		Amendments to Articles of Incorporation (15)
3.16		Amendments to Articles of Incorporation (16)
3.17		Amendments to Articles of Incorporation (17)
3.18		Amendments to Articles of Incorporation (18)
3.19		Amendments to Articles of Incorporation (22)
3.20		Amendments to Articles of Incorporation (26)
4.1		Form of Subscription Agreement (25)
4.2		Form of Convertible Promissory Note-Related Party (24)
4.3		Form of Promissory Note-Related Party (24)
10.1		Employment Agreement dated as of May 20, 2003, by and between StrikeForce Technologies, Inc. and Mark L. Kay (1)
10.2		Irrevocable Waiver of Conversion Rights of Mark L. Kay (4)
10.3		Irrevocable Waiver of Conversion Rights of Ramarao Pemmaraju (4)
10.4		Irrevocable Waiver of Conversion Rights of George Waller (4)
10.5		CFO Consultant Agreement with Philip E. Blocker (4)
10.6		2012 Stock Option Plan (5)
10.7		Asset Purchase Agreement between StrikeForce Technologies, Inc. and Cyber Safety, Inc., dated August 24, 2015 (18)
10.8		Amendment to the Asset Purchase Agreement and Distributor and Reseller Agreement between StrikeForce Technologies, Inc. and Cyber Safety, Inc. (19)
10.9		Execution of Litigation Funding Agreement (20)
10.10		BlockSafe Technologies, Inc. Intellectual Property License Agreement (21)
10.11		BlockSafe Technologies, Inc. Management Agreement (21)
10.12		BlockSafe Technologies, Inc. Amended Management Agreement (21)
10.13		Software License and Development Agreement, amendment two, by and between StrikeForce Technologies, Inc. and Intersections, Inc., dated October 1, 2010 (24)
10.14		Form of Settlement and Exchange Agreement (26)
10.15		Cybersecurity Risk Solutions LLC Member Interest Purchase Agreement, dated April 15, 2021 (27)
31.1		Certification by Chief Executive Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act, promulgated pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. ~~(23)~~(29)
31.2		Certification by Chief Financial Officer, required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act, promulgated pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. ~~(23)~~(29)
32.1		Certification by Chief Executive Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, promulgated pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. ~~(23)~~(29)
32.2		Certification by Chief Financial Officer, required by Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code, promulgated pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. ~~(23)~~(29)
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). (29)
101.SCH		Inline XBRL Taxonomy Extension Schema Document. (29)
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document. (29)
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document. (29)
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document. (29)
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document. (29)
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). (29)

~~_______________~~

Table of Contents

________________

(1)	Filed as an exhibit to the Registrant’s Form SB-2 dated as of May 11, 2005 and incorporated herein by reference.
(2)	Filed as an exhibit to the Registrant’s Form 8-K dated February 4, 2011 and incorporated herein by reference.
(3)	Filed as an exhibit to the ~~Registrant’s~~Registrant's Form 10-Q dated December 13, 2010 and incorporated herein by ~~reference~~.reference.
(4)	Filed as an exhibit to the Registrant’s Form S-1/A dated July 31, 2012 and incorporated herein by reference.
(5)	Filed in conjunction withthe Registrant’s Form 14A filed October 5, 2012 and incorporated herein by reference.
(6)	Filed as an exhibit to the Registrant’s Form 8-K dated February 5, 2013 and incorporated herein by reference.
(7)	Filed as an exhibit to the Registrant’s Form 8-K dated May 14, 2013 and incorporated herein by reference.
(8)	Filed as an exhibit to the Registrant’s Form 8-A dated July 29, 2013 and incorporated herein by reference.
(9)	Filed as an exhibit to the Registrant’s Form 8-K dated August 22, 2013 and incorporated herein by reference.
(10)	Filed as an exhibit to the Registrant’s Form 8-A dated October 3, 2013 and incorporated herein by reference.
(11)	Filed as an exhibit to the Registrant’s Form 8-K dated October 3, 2013 and incorporated herein by reference.
(12)	Filed as an exhibit to the Registrant’s Form 8-A dated December 31, 2013 and incorporated herein by reference.
(13)	Filed as an exhibit to the Registrant’s Form 8-K dated December 31, 2013 and incorporated herein by reference.
(14)	Filed as an exhibit to the Registrant’s Form 8-K dated March 18, 2014 and incorporated herein by reference.
(15)	Filed as an exhibit to the Registrant’s Form 8-K dated December 22, 2014 and incorporated herein by reference.
(16)	Filed as an exhibit to the Registrant’s Form 8-K dated February 13, 2015 and incorporated herein by reference.
(17)	Filed as an exhibit to the Registrant’s Form 8-K dated August 4, 2015 and incorporated herein by reference.
(18)	Filed as an exhibit to the Registrant’s Form 8-K dated ~~July 16, 2019~~August 24, 2015 and incorporated herein by reference.
(19)	Filed as an exhibit to the Registrant’s Form 8-K dated February 2, 2016 and incorporated herein by reference.
(20)	Filed as an exhibit to the Registrant’s Form 8-K dated September 11, 2017 and incorporated herein by reference.
(21)	Filed as an exhibit to the Registrant’s Form 10-Q dated June 30, 2018 and incorporated herein by reference.
(22)	Filed as an exhibit to the Registrant’s Form 8-K dated June 25, 2020 and incorporated herein by reference.
(23)	Filed as an exhibit to the Registrant’s Form 1-A dated July 13, 2020 and incorporated herein by reference.
(24)	Filed as an exhibit to the Registrant’s Form 1-A.1 dated September 11, 2020 and incorporated herein by reference.
(25)	Filed as an exhibit to the Registrant’s Form 1-A.1 dated November 12, 2020 and incorporated herein by reference.
(26)	Filed as an exhibit to the Registrant’s Form 8-K dated February 8, 2021 and incorporated herein by reference.
(27)	Filed as an exhibit to the Registrant’s Form 8-K dated April 19, 2021 and incorporated herein by reference.
(28)	Filed as an exhibit to the Registrant’s Form 1A/A- dated April 26, 2021 and incorporated herein by reference.
(29)	Filed herewith.

2931

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	STRIKEFORCE TECHNOLOGIES, INC.

Dated: August ~~19, 2020~~20, 2021	By:	/s/ Mark L. Kay
		Mark L. Kay
		Chief Executive Officer

Dated: August ~~19, 2020~~20, 2021	By:	/s/ Philip E. Blocker
		Philip E. Blocker
		Chief Financial Officer and ~~Principal Accounting Officer~~
		Principal Accounting Officer

3032